| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCF1 ABCA4 ATP7A MCM8 EIF4A3 ZGRF1 SMC1A KIF4A MCM4 ATP9B DHX8 HSPA13 BLM RAD54B DDX54 DNAH6 EP400 DYNC2H1 DDX60 ABCB5 RNF213 CCT7 ATP8B2 RAD50 ENTPD1 MACF1 KIF4B TOP2A TOP2B TDRD12 | 2.72e-10 | 614 | 253 | 30 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCF1 ABCA4 ATP7A MCM8 EIF4A3 SMC1A MCM4 ATP9B DHX8 HSPA13 BLM DDX54 DNAH6 DYNC2H1 DDX60 ABCB5 RNF213 CCT7 ATP8B2 RAD50 ENTPD1 MACF1 TDRD12 | 1.12e-08 | 441 | 253 | 23 | GO:0016887 |
| GeneOntologyMolecularFunction | helicase activity | MCM8 EIF4A3 ZGRF1 MCM4 DHX8 BLM RAD54B DDX54 EP400 DDX60 RAD50 TDRD12 | 8.47e-07 | 158 | 253 | 12 | GO:0004386 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCF1 ABCA4 ATP7A MCM8 EIF4A3 SMC1A GBP3 MCM4 ATP9B DHX8 HSPA13 BLM DDX54 GNL2 DNAH6 DYNC2H1 DDX60 ABCB5 RNF213 CCT7 ATP8B2 RAD50 ENTPD1 MACF1 TDRD12 | 1.90e-05 | 775 | 253 | 25 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.53e-05 | 127 | 253 | 9 | GO:0008094 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCF1 ABCA4 ATP7A MCM8 EIF4A3 SMC1A GBP3 MCM4 ATP9B DHX8 HSPA13 BLM DDX54 GNL2 DNAH6 DYNC2H1 DDX60 ABCB5 RNF213 CCT7 ATP8B2 RAD50 ENTPD1 MACF1 TDRD12 | 6.91e-05 | 839 | 253 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCF1 ABCA4 ATP7A MCM8 EIF4A3 SMC1A GBP3 MCM4 ATP9B DHX8 HSPA13 BLM DDX54 GNL2 DNAH6 DYNC2H1 DDX60 ABCB5 RNF213 CCT7 ATP8B2 RAD50 ENTPD1 MACF1 TDRD12 | 7.04e-05 | 840 | 253 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCF1 ABCA4 ATP7A MCM8 EIF4A3 SMC1A GBP3 MCM4 ATP9B DHX8 HSPA13 BLM DDX54 GNL2 DNAH6 DYNC2H1 DDX60 ABCB5 RNF213 CCT7 ATP8B2 RAD50 ENTPD1 MACF1 TDRD12 | 7.04e-05 | 840 | 253 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.32e-04 | 62 | 253 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | heparanase activity | 1.60e-04 | 2 | 253 | 2 | GO:0030305 | |
| GeneOntologyMolecularFunction | alpha-L-arabinofuranosidase activity | 1.60e-04 | 2 | 253 | 2 | GO:0046556 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 4.67e-04 | 78 | 253 | 6 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 5.35e-04 | 80 | 253 | 6 | GO:0008186 | |
| GeneOntologyMolecularFunction | G-quadruplex DNA binding | 6.60e-04 | 14 | 253 | 3 | GO:0051880 | |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 9.43e-04 | 4 | 253 | 2 | GO:0003918 | |
| GeneOntologyCellularComponent | integrin complex | 4.00e-05 | 32 | 255 | 5 | GO:0008305 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 8.15e-05 | 59 | 255 | 6 | GO:0098636 | |
| GeneOntologyCellularComponent | integrin alpha6-beta1 complex | 1.48e-04 | 2 | 255 | 2 | GO:0034675 | |
| GeneOntologyCellularComponent | integrin alpha8-beta1 complex | 1.48e-04 | 2 | 255 | 2 | GO:0034678 | |
| GeneOntologyCellularComponent | extracellular matrix | ITGA6 HPSE2 HPSE ITGB1 SEMA6D OTOGL MMP16 MMP19 FRAS1 ABI3BP SFTPD APCS LAMC1 OMD LRRN3 PRELP ENTPD1 SERPINC1 EGFLAM OTOG | 1.71e-04 | 656 | 255 | 20 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ITGA6 HPSE2 HPSE ITGB1 SEMA6D OTOGL MMP16 MMP19 FRAS1 ABI3BP SFTPD APCS LAMC1 OMD LRRN3 PRELP ENTPD1 SERPINC1 EGFLAM OTOG | 1.78e-04 | 658 | 255 | 20 | GO:0030312 |
| GeneOntologyCellularComponent | integrin alpha4-beta1 complex | 4.41e-04 | 3 | 255 | 2 | GO:0034668 | |
| Domain | Integrin_dom | 1.87e-05 | 25 | 253 | 5 | IPR032695 | |
| Domain | Ferlin_B-domain | 2.41e-05 | 5 | 253 | 3 | IPR012561 | |
| Domain | Ferlin_C | 2.41e-05 | 5 | 253 | 3 | PF16165 | |
| Domain | FerIin_dom | 2.41e-05 | 5 | 253 | 3 | IPR012968 | |
| Domain | FerI | 2.41e-05 | 5 | 253 | 3 | PF08151 | |
| Domain | FerB | 2.41e-05 | 5 | 253 | 3 | PF08150 | |
| Domain | FerI | 2.41e-05 | 5 | 253 | 3 | SM01202 | |
| Domain | FerB | 2.41e-05 | 5 | 253 | 3 | SM01201 | |
| Domain | Ferlin_C | 2.41e-05 | 5 | 253 | 3 | IPR032362 | |
| Domain | - | OTOF PIK3CG SYT4 FER1L5 RASAL2 SYT10 SYT16 MYOF MCTP1 UNC13C | 3.45e-05 | 148 | 253 | 10 | 2.60.40.150 |
| Domain | C2 | 7.49e-05 | 131 | 253 | 9 | PF00168 | |
| Domain | C2_dom | OTOF PIK3CG SYT4 FER1L5 RASAL2 SYT10 SYT16 MYOF MCTP1 UNC13C | 8.23e-05 | 164 | 253 | 10 | IPR000008 |
| Domain | C2 | 1.06e-04 | 137 | 253 | 9 | SM00239 | |
| Domain | C2 | 1.39e-04 | 142 | 253 | 9 | PS50004 | |
| Domain | - | 1.83e-04 | 2 | 253 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 1.83e-04 | 2 | 253 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 1.83e-04 | 2 | 253 | 2 | PF00204 | |
| Domain | - | 1.83e-04 | 2 | 253 | 2 | 3.90.199.10 | |
| Domain | Glyco_hydro_79n | 1.83e-04 | 2 | 253 | 2 | PF03662 | |
| Domain | Topo_IIA_A/C_ab | 1.83e-04 | 2 | 253 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 1.83e-04 | 2 | 253 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 1.83e-04 | 2 | 253 | 2 | IPR013759 | |
| Domain | TOP4c | 1.83e-04 | 2 | 253 | 2 | SM00434 | |
| Domain | TOP2c | 1.83e-04 | 2 | 253 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 1.83e-04 | 2 | 253 | 2 | IPR013760 | |
| Domain | TOPRIM_C | 1.83e-04 | 2 | 253 | 2 | IPR031660 | |
| Domain | Topo_IIA_A/C | 1.83e-04 | 2 | 253 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 1.83e-04 | 2 | 253 | 2 | PS00177 | |
| Domain | Glyco_hydro_79 | 1.83e-04 | 2 | 253 | 2 | IPR005199 | |
| Domain | TopoIIA_CS | 1.83e-04 | 2 | 253 | 2 | IPR018522 | |
| Domain | Topo_IIA | 1.83e-04 | 2 | 253 | 2 | IPR001241 | |
| Domain | DNA_topoisoIV | 1.83e-04 | 2 | 253 | 2 | PF00521 | |
| Domain | Topo_IIA_bsu_dom2 | 1.83e-04 | 2 | 253 | 2 | IPR013506 | |
| Domain | DTHCT | 1.83e-04 | 2 | 253 | 2 | PF08070 | |
| Domain | - | 1.83e-04 | 2 | 253 | 2 | 1.10.268.10 | |
| Domain | TOPRIM_C | 1.83e-04 | 2 | 253 | 2 | PF16898 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.64e-04 | 73 | 253 | 6 | IPR011545 | |
| Domain | DEAD | 4.64e-04 | 73 | 253 | 6 | PF00270 | |
| Domain | Ferlin_A-domain | 5.43e-04 | 3 | 253 | 2 | IPR012560 | |
| Domain | Arg_repress_C-like | 5.43e-04 | 3 | 253 | 2 | IPR024946 | |
| Domain | FerA | 5.43e-04 | 3 | 253 | 2 | PF08165 | |
| Domain | - | 5.43e-04 | 3 | 253 | 2 | 3.30.1360.40 | |
| Domain | FerA | 5.43e-04 | 3 | 253 | 2 | SM01200 | |
| Domain | - | ABCF1 ABCA4 MCM8 EIF4A3 ZGRF1 SMC1A GBP3 MCM4 DHX8 BLM AK5 RAD54B DDX54 GNL2 DNAH6 EP400 DYNC2H1 DDX60 ABCB5 RNF213 RAD50 TDRD12 | 5.44e-04 | 746 | 253 | 22 | 3.40.50.300 |
| Domain | P-loop_NTPase | ABCF1 ABCA4 MCM8 EIF4A3 ZGRF1 SMC1A KIF4A GBP3 MCM4 DHX8 BLM AK5 RAD54B DDX54 GNL2 DNAH6 EP400 DYNC2H1 DDX60 ABCB5 RNF213 RAD50 KIF4B TDRD12 | 5.49e-04 | 848 | 253 | 24 | IPR027417 |
| Domain | Helicase_C | 6.36e-04 | 107 | 253 | 7 | PF00271 | |
| Domain | HELICc | 6.36e-04 | 107 | 253 | 7 | SM00490 | |
| Domain | Helicase_C | 6.72e-04 | 108 | 253 | 7 | IPR001650 | |
| Domain | DEXDc | 7.10e-04 | 109 | 253 | 7 | SM00487 | |
| Domain | HELICASE_CTER | 7.10e-04 | 109 | 253 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 7.10e-04 | 109 | 253 | 7 | PS51192 | |
| Domain | Helicase_ATP-bd | 7.50e-04 | 110 | 253 | 7 | IPR014001 | |
| Domain | AAA+_ATPase | 7.84e-04 | 144 | 253 | 8 | IPR003593 | |
| Domain | AAA | 7.84e-04 | 144 | 253 | 8 | SM00382 | |
| Domain | NDRG | 1.08e-03 | 4 | 253 | 2 | IPR004142 | |
| Domain | RNA_POL_L_13KD | 1.08e-03 | 4 | 253 | 2 | PS01154 | |
| Domain | Toprim_domain | 1.08e-03 | 4 | 253 | 2 | IPR006171 | |
| Domain | Rubredoxin-type_fold | 1.08e-03 | 4 | 253 | 2 | IPR004039 | |
| Domain | - | 1.08e-03 | 4 | 253 | 2 | 2.20.28.10 | |
| Domain | TOPRIM | 1.08e-03 | 4 | 253 | 2 | PS50880 | |
| Domain | Peroxin/Ferlin | 1.08e-03 | 4 | 253 | 2 | IPR006614 | |
| Domain | Ndr | 1.08e-03 | 4 | 253 | 2 | PF03096 | |
| Domain | Toprim | 1.08e-03 | 4 | 253 | 2 | PF01751 | |
| Domain | RNA_pol_Rpb11_13-16kDa_CS | 1.08e-03 | 4 | 253 | 2 | IPR008193 | |
| Domain | DysFC | 1.08e-03 | 4 | 253 | 2 | SM00694 | |
| Domain | DysFN | 1.08e-03 | 4 | 253 | 2 | SM00693 | |
| Domain | Integrin_alpha_C_CS | 1.21e-03 | 16 | 253 | 3 | IPR018184 | |
| Domain | INTEGRIN_ALPHA | 1.72e-03 | 18 | 253 | 3 | PS00242 | |
| Domain | Integrin_alpha | 1.72e-03 | 18 | 253 | 3 | IPR000413 | |
| Domain | Integrin_alpha-2 | 1.72e-03 | 18 | 253 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 1.72e-03 | 18 | 253 | 3 | PF08441 | |
| Domain | - | 1.78e-03 | 5 | 253 | 2 | 3.30.43.10 | |
| Domain | FAD-bd_2_sub1 | 1.78e-03 | 5 | 253 | 2 | IPR016167 | |
| Domain | Int_alpha | 2.03e-03 | 19 | 253 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.03e-03 | 19 | 253 | 3 | IPR013519 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 2.44e-05 | 26 | 194 | 5 | M47 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | GBF1 C5orf22 SMC1A CD109 RPS15 MCM4 PSMD8 NCK1 NCL ITGB1 DUSP22 TXNL1 PTPN14 DDX54 XRN1 TXNDC16 PRRC2A SDHA PUS7 PTCD3 FLNB TBC1D15 DNAJC16 RANBP9 LAMC1 CCT7 ANKRD50 RAD50 CNNM4 PTPDC1 LNPEP OSBPL3 | 2.06e-12 | 974 | 257 | 32 | 28675297 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ABCF1 ILF3 EIF4A3 SMC1A MCM4 NCL ITGB1 DHX8 SLC25A3 DDX54 GNL2 ZNF638 SNX9 FOXC1 FLNB TBC1D15 LIMA1 EP400 COPA NUDT21 MPZL1 LAMC1 CCT7 AGPS TBL3 RAD50 SEC24C CEBPZ MACF1 MMAB TOP2A TOP2B | 7.61e-12 | 1024 | 257 | 32 | 24711643 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ILF3 ORC3 EIF4A3 SMC1A RPS15 KIF4A MCM4 NCL BLM SLC25A3 GLS DDX54 GNL2 ZNF638 SNU13 RRP7A PTCD3 FLNB VRK2 COPA NUDT21 SGCD PARP2 TBL3 AKAP8L RAD50 MYL12A SEC24C CEBPZ TOP2A TOP2B | 1.54e-11 | 989 | 257 | 31 | 36424410 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ABCF1 ILF3 EIF4A3 SMC1A CD109 RPS15 ITGA6 NCL ITGA4 MECP2 DHX8 SLC25A3 PTPN14 GLS DDX54 GNL2 ZNF638 SDHA RASAL2 PTCD3 FLNB LIMA1 MAP7D3 COPA NUDT21 DDX60 PARP2 CCT7 NCAPH MTPAP TBL3 RAD50 MYOF CEBPZ TOP2A | 1.81e-11 | 1257 | 257 | 35 | 36526897 |
| Pubmed | ILF3 ZGRF1 NEB OTOF BRPF1 DDX54 SDHA FLNB LIMA1 CDC42BPA DNAJC16 DDX60 RAD50 MACF1 TOP2A TOP2B | 2.70e-11 | 234 | 257 | 16 | 36243803 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ABCF1 ILF3 EIF4A3 SMC1A RPS15 KIF4A MCM4 NCL SSB ITGB1 DHX8 SLC25A3 TXNL1 DDX54 GNL2 ZNF638 SNU13 PRRC2A SDHA PUS7 PTCD3 FLNB COPA NUDT21 FNBP4 RANBP9 CCT7 AHCYL2 NCAPH RAD50 MYL12A SEC24C CEBPZ MACF1 MRPL41 TOP2A TOP2B | 2.73e-11 | 1415 | 257 | 37 | 28515276 |
| Pubmed | TDRD15 ATP7A KIF4A NCL ITGB1 BLM FAT1 XRN1 ZNF638 HCFC2 FERMT2 RASAL2 ARAP2 PTCD3 CDC42BPA MAP7D3 EP400 DNAJC16 MPZL1 RNF213 CCT7 APOB AGPS ANKRD50 NCAPH AP4E1 SEC24C | 3.53e-11 | 777 | 257 | 27 | 35844135 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ILF3 RNF168 ORC3 EIF4A3 SMC1A KIF4A NCL MECP2 DHX8 BLM SLC25A3 CACTIN DDX54 ZNF638 SNU13 RRP7A CDYL HCFC2 FOXC1 VRK2 MAP7D3 EP400 COPA NUDT21 PARP2 FNBP4 TBL3 RAD50 CEBPZ OSBPL3 STEEP1 PAXIP1 TIGD5 TOP2A TOP2B | 3.99e-11 | 1294 | 257 | 35 | 30804502 |
| Pubmed | CDK18 ABCF1 ILF3 ATP7A PSMD8 NCL ITGB1 HSPA13 BLM TXNL1 CACTIN PTPN14 GLS DDX54 GNL2 FERMT2 SDHA PUS7 RASAL2 PTCD3 FRAS1 TBC1D15 VRK2 CDC42BPA DYNC2H1 DNAJC16 FNBP4 LAMC1 TBL3 SEC24C CEBPZ LNPEP MACF1 MRPL41 MMAB MRPL9 TOP2B | 1.11e-10 | 1487 | 257 | 37 | 33957083 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ABCF1 ILF3 RNF168 EIF4A3 SMC1A CD109 RPS15 MCM4 NCL DHX8 SLC25A3 CACTIN DDX54 GNL2 RRP7A FLNB LIMA1 MAP7D3 COPA NUDT21 PARP2 CCT7 APOB TBL3 CEBPZ OSBPL3 STEEP1 MRPL9 TOP2A | 1.33e-10 | 949 | 257 | 29 | 36574265 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ABCF1 ILF3 EIF4A3 SMC1A RPS15 KIF4A MCM4 NCL BLM SLC25A3 PTPN14 GLS DDX54 XRN1 IQSEC1 ZNF638 FERMT2 RASAL2 PTCD3 FLNB EP400 COPA RANBP9 CCT7 AGPS NCAPH MTPAP TBL3 AKAP8L RAD50 SEC24C CEBPZ MACF1 TOP2A TOP2B | 1.33e-10 | 1353 | 257 | 35 | 29467282 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ABCF1 ILF3 ORC3 MCM4 NCL SSB BLM DDX54 GNL2 SNU13 SNX9 EP400 FNBP4 CCT7 AGPS TBL3 AKAP8L CEBPZ TOP2A TOP2B | 1.40e-10 | 440 | 257 | 20 | 34244565 |
| Pubmed | ABCF1 RPS15 KIF4A MCM4 NCL SSB DHX8 BLM DDX54 XRN1 GNL2 ZNF638 RRP7A SNX9 PRRC2A SDHA PTCD3 FLNB COPA TBL3 RAD50 SEC24C CEBPZ MACF1 | 1.50e-10 | 653 | 257 | 24 | 22586326 | |
| Pubmed | ILF3 SMC1A RPS15 NCL SSB DHX8 BRPF1 DDX54 GNL2 ZNF638 SNU13 RRP7A HCFC2 PRRC2A FOXC1 FLNB LIMA1 CDC42BPA NUDT21 FNBP4 TBL3 AKAP8L MYL12A CEBPZ OSBPL3 TOP2A TOP2B | 2.39e-10 | 847 | 257 | 27 | 35850772 | |
| Pubmed | WBP2 ABCF1 ILF3 IMPDH1 EIF4A3 SMC1A RPS15 KIF4A MCM4 NCL SSB ITGB1 DHX8 SLC25A3 PTPN14 DDX54 XRN1 SNU13 PRRC2A SDHA LIMA1 CDC42BPA COPA NUDT21 RANBP9 CCT7 MED13L MTPAP AKAP8L MYOF SEC24C CEBPZ TOP2A | 2.66e-10 | 1247 | 257 | 33 | 27684187 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ABCF1 ILF3 ORC3 EIF4A3 SMC1A RPS15 MCM4 NCL SSB SLC25A3 TXNL1 CACTIN DDX54 GNL2 IQSEC1 SNU13 RRP7A CDYL SDHA PTCD3 VRK2 EP400 COPA NUDT21 PARP2 AGPS NCAPH MTPAP TBL3 AKAP8L SEC24C CEBPZ TOP2A TOP2B | 2.70e-10 | 1318 | 257 | 34 | 30463901 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ABCF1 ILF3 EIF4A3 SMC1A RPS15 NCL SSB DHX8 CACTIN DDX54 XRN1 GNL2 ZNF638 SNU13 PRRC2A PUS7 PTCD3 FLNB NUDT21 MTPAP AKAP8L CEBPZ MACF1 MRPL41 MRPL9 TOP2A | 4.20e-10 | 807 | 257 | 26 | 22681889 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ILF3 KIF4A NCL SSB MECP2 DHX8 BLM CACTIN GNL2 ZNF638 TAF1 EP400 NUDT21 STEEP1 TOP2A TOP2B | 4.50e-10 | 283 | 257 | 16 | 30585729 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ABCF1 GBF1 ILF3 EIF4A3 SMC1A MCM4 PSMD8 NCL SSB DHX8 SLC25A3 GLS DDX54 GNL2 SNU13 RRP7A SDHA RASAL2 PTCD3 FLNB TBC1D15 COPA DYNC2H1 NUDT21 DUOX2 CCT7 APOB AGPS NCAPH TBL3 RAD50 MYL12A CEBPZ TOP2A TOP2B | 5.26e-10 | 1425 | 257 | 35 | 30948266 |
| Pubmed | ILF3 ATP7A SMC1A MCM4 NCK1 THSD1 ITGB1 SLC25A3 TXNL1 XRN1 FERMT2 SNX9 PRRC2A SDHA RASAL2 FLNB TBC1D15 CDC42BPA MAP7D3 COPA CCT7 ANKRD50 SEC24C MACF1 | 7.54e-10 | 708 | 257 | 24 | 39231216 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | ILF3 SMC1A KIF4A MCM4 NCL BLM GNL2 ZNF638 LIMA1 EP400 RAD50 CEBPZ STEEP1 TOP2A TOP2B | 2.13e-09 | 271 | 257 | 15 | 32433965 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ABCF1 PNMA1 EIF4A3 SMC1A KIF4A NCL SSB DHX8 BLM DDX54 XRN1 GNL2 SNU13 RRP7A PRRC2A MAP7D3 COPA MTPAP TBL3 AKAP8L CEBPZ MACF1 TOP2A TOP2B | 2.95e-09 | 759 | 257 | 24 | 35915203 |
| Pubmed | PNMA1 C5orf22 MCM8 SCEL MECP2 CACTIN FAT1 PTPN14 BRPF1 XRN1 GNL2 IQSEC1 TAF1 FOXC1 ARAP2 PTCD3 TRAF7 EP400 RANBP9 RNF213 MTPAP AKAP8L RAD50 ZNF8 MCTP1 OSBPL3 MACF1 TIGD5 TOP2A | 5.28e-09 | 1116 | 257 | 29 | 31753913 | |
| Pubmed | SMC1A BLM DDX54 GNL2 SNU13 RRP7A TBL3 RAD50 MYOF CEBPZ RP1 TOP2A TOP2B | 6.03e-09 | 208 | 257 | 13 | 11790298 | |
| Pubmed | WBP2 KIF4A NCK1 SLC25A3 PTPN14 XRN1 TAF1 SNX9 PRRC2A TBC1D15 LIMA1 MAP7D3 EP400 NUDT21 FNBP4 NCAPH RAD50 CEBPZ STEEP1 TOP2A | 6.27e-09 | 549 | 257 | 20 | 38280479 | |
| Pubmed | CD109 RPS15 SSB HPSE ITGB1 SLC25A3 DDX54 GNL2 SNU13 HCFC2 SNX9 PRRC2A SDHA PTCD3 FLNB TBC1D15 COPA NUDT21 DDX60 PARP2 RANBP9 RNF213 LAMC1 CCT7 NCAPH AKAP8L RAD50 CNNM4 MYOF CEBPZ MRPL9 TOP2A TOP2B | 9.36e-09 | 1440 | 257 | 33 | 30833792 | |
| Pubmed | ABCF1 GBF1 ILF3 ATP7A EIF4A3 MFSD6 RPS15 KIF4A MCM4 NCL ITGA4 ITGB1 SLC25A3 PIK3CG DDX54 XRN1 GNL2 IQSEC1 PRRC2A MAP7D3 COPA RNF213 AGPS NCAPH RAD50 LNPEP OSBPL3 MARCHF5 ENTPD1 | 1.43e-08 | 1168 | 257 | 29 | 19946888 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ABCF1 GBF1 ILF3 SMC1A MCM4 NCL MECP2 BLM CACTIN BRPF1 IQSEC1 ZNF638 PRRC2A LIMA1 EP400 COPA FNBP4 AKAP8L RAD50 MYOF SEC24C TOP2A TOP2B | 2.01e-08 | 774 | 257 | 23 | 15302935 |
| Pubmed | ABCF1 ILF3 EIF4A3 RPS15 NCL SSB DHX8 DDX54 GNL2 ZNF638 SNU13 PRRC2A PTCD3 CDC42BPA COPA NUDT21 AKAP8L MYL12A MRPL41 MRPL9 TOP2A TOP2B | 2.14e-08 | 713 | 257 | 22 | 29802200 | |
| Pubmed | ABCF1 IMPDH1 ORC3 RPS15 KIF4A DENND2D MECP2 DHX8 BLM SLC25A3 XRN1 GNL2 RRP7A CDYL HCFC2 PRRC2A SDHA PTCD3 VRK2 CDC42BPA EP400 DNAJC16 PARP2 CCT7 MTPAP TBL3 AKAP8L MYL12A MYOF CEBPZ LNPEP MACF1 MRPL9 | 2.36e-08 | 1497 | 257 | 33 | 31527615 | |
| Pubmed | GBF1 ILF3 IMPDH1 NCL SSB ITGB1 MECP2 SLC25A3 CACTIN GNL2 IQSEC1 SNU13 RRP7A C5 PRRC2A PTCD3 VRK2 CDC42BPA EP400 COPA NUDT21 FNBP4 LAMC1 APOB AGPS MTPAP AKAP8L MYL12A SEC24C CEBPZ OSBPL3 | 3.71e-08 | 1371 | 257 | 31 | 36244648 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | GBF1 NCL SLC25A3 XRN1 PRRC2A FLNB CDC42BPA COPA DDX60 LAMC1 MYOF TOP2B | 4.10e-08 | 202 | 257 | 12 | 33005030 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ABCF1 ILF3 EIF4A3 SMC1A NCL MECP2 DHX8 BLM SLC25A3 TXNL1 GNL2 IQSEC1 ZNF638 PTCD3 CDC42BPA EP400 COPA NUDT21 FNBP4 AGPS AKAP8L ZNF8 MYL12A SEC24C MACF1 MRPL41 TOP2B | 4.23e-08 | 1082 | 257 | 27 | 38697112 |
| Pubmed | ILF3 SMC1A NCL ITGB1 BLM XRN1 ZNF638 PRRC2A LIMA1 COPA NUDT21 RAD50 MYOF TOP2A TOP2B | 4.42e-08 | 340 | 257 | 15 | 24332808 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | ORC3 EIF4A3 SMC1A KIF4A MCM4 SSB BLM DDX54 ZNF638 TAF1 PRRC2A EP400 PARP2 NCAPH SEC24C TOP2A | 4.90e-08 | 394 | 257 | 16 | 27248496 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ILF3 EIF4A3 SMC1A KIF4A MCM4 NCL MECP2 BLM SLC25A3 GNL2 ZNF638 SNU13 TAF1 PRRC2A FOXC1 MAP7D3 EP400 NUDT21 FNBP4 TBL3 MYL12A CEBPZ STEEP1 TOP2A TOP2B | 5.47e-08 | 954 | 257 | 25 | 36373674 |
| Pubmed | EIF4A3 CD109 NCL ITGB1 HSPA13 SLC25A3 FAT1 GLS CDYL FLNB TBC1D15 LIMA1 VRK2 MAP7D3 COPA NUDT21 MPZL1 LAMC1 CCT7 APOB AGPS MTPAP TBL3 MYOF SEC24C LNPEP CHEK2 MACF1 MMAB | 1.34e-07 | 1297 | 257 | 29 | 33545068 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ABCF1 ILF3 KIF4A MCM4 NCL SLC25A3 XRN1 GNL2 ZNF638 FERMT2 SNX9 PRRC2A PUS7 LIMA1 MAP7D3 EP400 CCT7 NCAPH RAD50 STEEP1 NCOA7 MACF1 TOP2A TOP2B | 1.46e-07 | 934 | 257 | 24 | 33916271 |
| Pubmed | WBP2 ABCF1 ILF3 EIF4A3 SMC1A RPS15 NCL SLC25A3 PTPN14 GNL2 ZNF638 SNU13 PRRC2A NUDT21 MTPAP TBL3 SEC24C TOP2A TOP2B | 1.98e-07 | 615 | 257 | 19 | 31048545 | |
| Pubmed | ASXL1 MCM4 NCL FAT1 PTPN14 BRPF1 PRRC2A FLNB COPA LAMC1 CDCP1 MYOF MACF1 TOP2A | 2.17e-07 | 332 | 257 | 14 | 37433992 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ABCF1 ORC3 SMC1A KIF4A MCM4 NCL ZNF638 TAF1 FLNB EP400 COPA RNF213 RAD50 TOP2A | 2.17e-07 | 332 | 257 | 14 | 32786267 |
| Pubmed | ABCA4 WDR64 ORC3 ZNF227 NEB CSMD2 GLS RRP7A C5 FER1L5 RASAL2 MAP7D3 DYNC2H1 LAMC1 TBL3 PRELP PAXIP1 MRPL41 TIGD5 | 3.46e-07 | 638 | 257 | 19 | 31182584 | |
| Pubmed | GBF1 ILF3 EIF4A3 SMC1A MCM4 PSMD8 SSB SLC25A3 FLNB TBC1D15 COPA NUDT21 DNAJC16 CCT7 TBL3 RAD50 MYL12A SEC24C TOP2B | 3.46e-07 | 638 | 257 | 19 | 33239621 | |
| Pubmed | ITGA6 PSMD8 SSB ITGB1 SLC25A3 SNU13 MGAM FLNB COPA APCS CCT7 NDRG4 | 3.96e-07 | 249 | 257 | 12 | 30097533 | |
| Pubmed | Integrins mediate adherence and migration of T lymphocytes on human peritoneal mesothelial cells. | 3.99e-07 | 3 | 257 | 3 | 18614994 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | ACADS RPS15 SLC25A3 COPA DDX60 RNF213 CCT7 RAD50 RP1 OTOG TDRD12 | 4.86e-07 | 208 | 257 | 11 | 33230847 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ASXL1 GBF1 ORC3 SMC1A KIF4A MCM4 PSMD8 ITGB1 MECP2 BLM SNX9 FOXC1 MAP7D3 EP400 COPA PARP2 NCAPH MTPAP RAD50 CHEK2 TOP2A TOP2B | 5.03e-07 | 857 | 257 | 22 | 25609649 |
| Pubmed | GBF1 KIF4A BLM ZNF638 RRP7A CDYL LIMA1 NCAPH CEBPZ TOP2A TOP2B | 5.34e-07 | 210 | 257 | 11 | 16565220 | |
| Pubmed | 5.91e-07 | 10 | 257 | 4 | 3384439 | ||
| Pubmed | ILF3 EIF4A3 SMC1A RPS15 NCL SSB SLC25A3 DDX54 GNL2 SNU13 PRRC2A NUDT21 FNBP4 CCT7 MTPAP TBL3 AKAP8L CEBPZ MRPL41 TOP2A | 6.38e-07 | 731 | 257 | 20 | 29298432 | |
| Pubmed | ILF3 RNF168 ORC3 EIF4A3 SMC1A KIF4A MCM4 NCL BLM TXNL1 CACTIN TAF1 PUS7 EP400 COPA RNF213 CCT7 MED13L NCAPH TBL3 RAD50 STEEP1 TOP2A TOP2B | 6.38e-07 | 1014 | 257 | 24 | 32416067 | |
| Pubmed | ILF3 EIF4A3 SMC1A MCM4 DHX8 BLM DDX54 GNL2 SNU13 NUDT21 TBL3 RAD50 CEBPZ TOP2A TOP2B | 6.43e-07 | 419 | 257 | 15 | 15635413 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ABCF1 ILF3 EIF4A3 SMC1A RPS15 NCL SLC25A3 DDX54 GNL2 ZNF638 SNU13 RRP7A FNBP4 TBL3 AKAP8L CEBPZ TOP2A TOP2B | 7.21e-07 | 605 | 257 | 18 | 28977666 |
| Pubmed | 7.64e-07 | 99 | 257 | 8 | 27746211 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RNF168 SMC1A KIF4A MECP2 DHX8 BLM CACTIN BRPF1 RAD54B DDX54 GNL2 CDYL TAF1 FOXC1 ZNF8 STEEP1 TOP2A TOP2B | 7.73e-07 | 608 | 257 | 18 | 36089195 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | ATP7A ITGA4 ITGB1 SLC25A3 PTPN14 FERMT2 SNX9 RASAL2 VRK2 CDC42BPA MPZL1 ANKRD50 CNNM4 MYOF | 9.92e-07 | 377 | 257 | 14 | 38117590 |
| Pubmed | ABCF1 ILF3 EIF4A3 RPS15 PSMD8 NCL SSB SLC25A3 PTPN14 DDX54 GNL2 SNU13 PRRC2A SDHA PTCD3 FLNB COPA NUDT21 CCT7 AKAP8L CEBPZ MRPL41 UNC13C | 1.09e-06 | 971 | 257 | 23 | 33306668 | |
| Pubmed | RPS15 ITGA6 PSMD8 ITGB1 DUSP22 BLM CACTIN PTPN14 DDX54 GNL2 ZNF638 PRRC2A FOXC1 VRK2 CDC42BPA COPA MPZL1 RNF213 CCT7 AKAP8L CNNM4 PTPDC1 CEBPZ LNPEP | 1.16e-06 | 1049 | 257 | 24 | 27880917 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CDK18 ASXL1 MAK EIF4A3 SMC1A NCL DYRK4 NEB DHX8 DDX54 SNU13 EP400 NUDT21 CILK1 LAMC1 AHCYL2 MED13L CHEK2 PRKG2 | 1.24e-06 | 695 | 257 | 19 | 23602568 |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | ILF3 MECP2 SLC25A3 DDX54 GNL2 SNU13 PTCD3 COPA CCT7 AKAP8L CEBPZ TOP2A TOP2B | 1.27e-06 | 330 | 257 | 13 | 33301849 |
| Pubmed | 1.50e-06 | 27 | 257 | 5 | 2574151 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.50e-06 | 27 | 257 | 5 | 31541017 | |
| Pubmed | 1.59e-06 | 4 | 257 | 3 | 19579970 | ||
| Pubmed | 1.59e-06 | 4 | 257 | 3 | 15331325 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ILF3 EIF4A3 ZGRF1 SMC1A RPS15 MCM4 PSMD8 NCL SNU13 DNAH6 SDHA PTCD3 FLNB LIMA1 COPA LAMC1 CCT7 NCAPH RAD50 MACF1 MMAB | 1.60e-06 | 847 | 257 | 21 | 35235311 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.71e-06 | 148 | 257 | 9 | 32538781 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK18 MAK ABCF1 GDAP2 SMC1A MCM4 PSMD8 SSB BLM PTPN14 ZNF638 MINDY4 FERMT2 SNX9 RASAL2 LIMA1 MAP7D3 DYNC2H1 RANBP9 CILK1 MTPAP RAD50 CNNM4 PTPDC1 DZANK1 OSBPL3 PRKG2 | 2.06e-06 | 1321 | 257 | 27 | 27173435 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | ABCF1 MCM4 MECP2 DDX54 GNL2 RRP7A FOXC1 COPA PARP2 LAMC1 TBL3 RAD50 CEBPZ | 2.35e-06 | 349 | 257 | 13 | 25665578 |
| Pubmed | ABCF1 ILF3 ORC3 EIF4A3 CD109 KIF4A TXNL1 SNU13 FLNB LIMA1 COPA TBL3 MYL12A MYOF MACF1 SERPINC1 TOP2A TOP2B | 2.46e-06 | 660 | 257 | 18 | 32780723 | |
| Pubmed | ABCF1 ILF3 C5orf22 ORC3 EIF4A3 RPS15 MCM4 PSMD8 NCL SSB SLC25A3 ZNF638 SNX9 PRRC2A SDHA PTCD3 NUDT21 DNAJC16 RANBP9 CCT7 AKAP8L RAD50 MYL12A SEC24C STEEP1 MRPL41 MRPL9 | 2.51e-06 | 1335 | 257 | 27 | 29229926 | |
| Pubmed | SMC1A MCM4 MECP2 CACTIN ZNF638 SNU13 PTCD3 EP400 NUDT21 NCAPH RAD50 CEBPZ STEEP1 TOP2A TOP2B | 2.58e-06 | 469 | 257 | 15 | 27634302 | |
| Pubmed | ILF3 ACADS ORC3 EIF4A3 SMC1A RPS15 MCM4 NCL SSB ITGB1 SLC25A3 GLS SNU13 FLNB COPA CCT7 AGPS MYL12A MYOF TOP2A | 2.67e-06 | 803 | 257 | 20 | 36517590 | |
| Pubmed | ILF3 PSMD8 ITGB1 MECP2 DHX8 BLM PUS7 VRK2 EP400 NUDT21 RANBP9 ANKRD50 RAD50 STEEP1 MACF1 | 2.79e-06 | 472 | 257 | 15 | 38943005 | |
| Pubmed | ASXL1 SMC1A RPS15 PSMD8 SSB BLM FAT1 DDX54 XRN1 GNL2 ZNF638 TAF1 HCFC2 PRRC2A FOXC1 PTCD3 LIMA1 CDC42BPA EP400 COPA CCT7 AKAP8L RAD50 MYL12A PAXIP1 MRPL41 FILIP1L SP7 | 2.96e-06 | 1429 | 257 | 28 | 35140242 | |
| Pubmed | NCL DDX54 ZNF638 SNU13 HCFC2 NUDT21 PARP2 MYL12A PAXIP1 TOP2A TOP2B | 3.05e-06 | 251 | 257 | 11 | 31076518 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ILF3 EIF4A3 SMC1A ITGA6 MCM4 NCL SSB DHX8 SLC25A3 SDHA PTCD3 FLNB LIMA1 CCT7 CEBPZ | 3.17e-06 | 477 | 257 | 15 | 31300519 |
| Pubmed | ILF3 EIF4A3 PSMD8 NCL NEB MECP2 GLS XRN1 SNU13 SNX9 DNAH6 FLNB LIMA1 ABI3BP COPA ABCB5 DUOX2 APOB AHCYL2 TEX14 NCAPH AKAP8L CEBPZ PCDHGA12 MACF1 TOP2A TOP2B MYBPC2 | 3.51e-06 | 1442 | 257 | 28 | 35575683 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | ILF3 EIF4A3 RPS15 NCL SLC25A3 CACTIN PTPN14 DDX54 GNL2 IQSEC1 SNU13 PRRC2A FOXC1 PTCD3 NUDT21 CCT7 TBL3 MRPL41 | 3.57e-06 | 678 | 257 | 18 | 30209976 |
| Pubmed | WBP2 ATP7A ITGA6 ITGA4 ITGB1 PTPN14 SEMA6D FERMT2 SDHA RASAL2 MPZL1 ANKRD50 AKAP8L MACF1 | 3.58e-06 | 421 | 257 | 14 | 36976175 | |
| Pubmed | ABCF1 RPS15 NCL DHX8 BLM DDX54 GNL2 ZNF638 SNU13 RRP7A PRRC2A TBL3 AKAP8L CEBPZ TOP2A | 3.69e-06 | 483 | 257 | 15 | 36912080 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | EIF4A3 SSB DHX8 GNL2 IQSEC1 ZNF638 SNU13 NUDT21 RANBP9 RAD50 CEBPZ TOP2A TOP2B | 3.72e-06 | 364 | 257 | 13 | 24778252 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | CD109 MCM4 NCL ITGB1 MECP2 SLC25A3 FAT1 PTPN14 GLS IQSEC1 DNAH6 SDHA PTCD3 FLNB COPA NUDT21 DNAJC16 RNF213 LAMC1 ACAD10 AGPS MYL12A ECHDC3 SEC24C LNPEP MRPL41 MMAB MRPL9 | 3.94e-06 | 1451 | 257 | 28 | 30550785 |
| Pubmed | 3.94e-06 | 5 | 257 | 3 | 15466886 | ||
| Pubmed | 3.94e-06 | 5 | 257 | 3 | 19193855 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ABCF1 GBF1 IMPDH1 EIF4A3 SMC1A RPS15 MCM4 PSMD8 NCL SSB TXNL1 GLS SNU13 FERMT2 PUS7 FLNB TBC1D15 COPA NUDT21 RANBP9 CCT7 ARMC9 NCAPH MYL12A SEC24C LNPEP NCOA7 MACF1 | 4.15e-06 | 1455 | 257 | 28 | 22863883 |
| Pubmed | ILF3 EIF4A3 MCM4 NCL ITGA4 ITGB1 SNU13 SDHA FLNB COPA NUDT21 CCT7 MYL12A SEC24C TOP2A | 4.50e-06 | 491 | 257 | 15 | 22623428 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | ILF3 EIF4A3 SMC1A RPS15 NCL SSB MECP2 SLC25A3 SNU13 SDHA CCT7 TBL3 TOP2A TOP2B | 4.57e-06 | 430 | 257 | 14 | 38172120 |
| Pubmed | ABCF1 ACADS NCL TXNL1 CAMKV GLS XRN1 IQSEC1 SYN2 FERMT2 SDHA PTCD3 FLNB CDC42BPA DNAJC16 RANBP9 CCT7 AHCYL2 GRM5 AKAP8L MYL12A DZANK1 MACF1 NDRG4 | 4.72e-06 | 1139 | 257 | 24 | 36417873 | |
| Pubmed | Integrin requirement for hippocampal synaptic plasticity and spatial memory. | 4.94e-06 | 16 | 257 | 4 | 12904471 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | ILF3 RPS15 KIF4A PSMD8 NCL MECP2 SLC25A3 SNU13 PTCD3 FLNB LIMA1 NUDT21 RAD50 CEBPZ OSBPL3 KIF4B TOP2A | 4.97e-06 | 626 | 257 | 17 | 33644029 |
| Pubmed | ORC3 SMC1A MCM4 DHX8 SLC25A3 GLS SNX9 SDHA PTCD3 TBC1D15 LIMA1 COPA RANBP9 TBL3 RAD50 TOP2A | 5.03e-06 | 560 | 257 | 16 | 35241646 | |
| Pubmed | GBF1 ARHGEF16 TXNL1 XRN1 FERMT2 FLNB TBC1D15 LIMA1 MAP7D3 MYOF | 5.31e-06 | 216 | 257 | 10 | 31519766 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ABCF1 GBF1 ILF3 SMC1A RPS15 MCM4 NCL SSB SNU13 HCFC2 SNX9 PRRC2A PTCD3 FLNB LIMA1 COPA NUDT21 RANBP9 CCT7 NCAPH AKAP8L RAD50 MYL12A MACF1 | 5.47e-06 | 1149 | 257 | 24 | 35446349 |
| Pubmed | CDK18 MAK ILF3 EIF4A3 SMC1A RPS15 MCM4 PSMD8 NCL SSB SLC25A3 SNU13 PTCD3 COPA RANBP9 CILK1 CCT7 AHCYL2 NCAPH MYL12A MACF1 MRPL41 MRPL9 EPB42 | 5.80e-06 | 1153 | 257 | 24 | 29845934 | |
| Pubmed | ABCF1 ILF3 EIF4A3 SMC1A RPS15 KIF4A NCL MECP2 GNL2 PRRC2A MAP7D3 COPA RAD50 TOP2A | 6.08e-06 | 441 | 257 | 14 | 31239290 | |
| Pubmed | ABCF1 ILF3 EIF4A3 RPS15 MCM4 NCL SSB ITGA4 ITGB1 SNU13 SDHA FLNB COPA NUDT21 CCT7 SEC24C MACF1 TOP2A | 6.33e-06 | 707 | 257 | 18 | 19738201 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | ILF3 RPS15 NCL SLC25A3 DDX54 PTCD3 COPA TBL3 AKAP8L MYL12A CEBPZ | 6.55e-06 | 272 | 257 | 11 | 25315684 |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 6.68e-06 | 62 | 257 | 6 | 26508657 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ILF3 NCL SSB ITGB1 BLM TXNL1 PTPN14 GLS DDX54 GNL2 MINDY4 SDHA PTCD3 TBC1D15 VRK2 MAP7D3 COPA RNF213 CCT7 AHCYL2 MTPAP TBL3 OSBPL3 MARCHF5 MRPL41 MMAB MRPL9 TOP2A | 6.96e-06 | 1496 | 257 | 28 | 32877691 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RPS15 MCM4 PSMD8 ITGB1 SLC25A3 SDHA PTCD3 FLNB TBC1D15 LIMA1 COPA NCAPH MYL12A SEC24C SERPINC1 MRPL41 TOP2A | 7.65e-06 | 647 | 257 | 17 | 26618866 |
| Interaction | SIRT6 interactions | ABCF1 ILF3 ORC3 SMC1A KIF4A MCM4 NCL SSB BLM FAT1 DDX54 GNL2 SNU13 SNX9 FLNB EP400 PARP2 FNBP4 CCT7 AGPS TBL3 AKAP8L RAD50 CEBPZ TOP2A TOP2B | 1.07e-07 | 628 | 253 | 26 | int:SIRT6 |
| Interaction | CIT interactions | ABCF1 ILF3 ORC3 EIF4A3 SMC1A CD109 RPS15 MCM4 NCL SSB ITGA4 MAP3K5 DHX8 SLC25A3 CACTIN PIK3CG GNL2 ZNF638 SNU13 RRP7A CDYL FERMT2 PRRC2A SDHA RASAL2 FLNB LIMA1 VRK2 EP400 COPA DYNC2H1 DDX60 RNF213 DUOX2 APOB SYT10 TBL3 AKAP8L SEC24C CEBPZ MACF1 TOP2A TOP2B | 1.12e-07 | 1450 | 253 | 43 | int:CIT |
| Interaction | KCNA3 interactions | ILF3 ATP7A ACADS SMC1A RPS15 MCM4 NCK1 THSD1 ITGB1 SLC25A3 TXNL1 XRN1 FERMT2 SNX9 PRRC2A SDHA RASAL2 FLNB TBC1D15 CDC42BPA MAP7D3 COPA RNF213 CCT7 ANKRD50 RAD50 SEC24C MACF1 RP1 OTOG TDRD12 | 1.79e-07 | 871 | 253 | 31 | int:KCNA3 |
| Interaction | H2BC4 interactions | ABCF1 EIF4A3 MCM4 NCL SSB ITGA4 NEB BRPF1 XRN1 ZNF638 PRRC2A SDHA PARP2 TOP2B | 5.40e-06 | 259 | 253 | 14 | int:H2BC4 |
| Interaction | XRCC6 interactions | ASXL1 ILF3 IMPDH1 ORC3 SMC1A KIF4A NCL SSB ITGA4 MECP2 DHX8 BLM SLC25A3 CACTIN GNL2 ZNF638 SNU13 TAF1 SDHA EP400 NUDT21 PARP2 RAD50 STEEP1 PAXIP1 CHEK2 MOB3C TOP2A TOP2B | 6.06e-06 | 928 | 253 | 29 | int:XRCC6 |
| Interaction | SIRT7 interactions | ABCF1 RPS15 KIF4A MCM4 NCL SSB DHX8 BLM DDX54 XRN1 GNL2 ZNF638 RRP7A SNX9 PRRC2A SDHA PTCD3 FLNB COPA TBL3 RAD50 SEC24C CEBPZ MACF1 TOP2A | 8.16e-06 | 744 | 253 | 25 | int:SIRT7 |
| Interaction | C11orf52 interactions | ATP7A ITGA6 ITGB1 PTPN14 FERMT2 SNX9 RASAL2 ARAP2 CDC42BPA MPZL1 AHCYL2 ANKRD50 CNNM4 LNPEP MACF1 | 9.88e-06 | 311 | 253 | 15 | int:C11orf52 |
| Interaction | TNIP1 interactions | ABCF1 ILF3 RNF168 EIF4A3 SMC1A CD109 RPS15 MCM4 NCL DHX8 SLC25A3 CACTIN DDX54 GNL2 RRP7A SDHA FLNB LIMA1 MAP7D3 COPA NUDT21 PARP2 CCT7 APOB TEX14 TBL3 CEBPZ OSBPL3 STEEP1 TCEANC2 MOB3C HAO2 MRPL9 TOP2A | 1.02e-05 | 1217 | 253 | 34 | int:TNIP1 |
| Interaction | DOT1L interactions | ILF3 SMC1A NCL SSB DHX8 BRPF1 DDX54 GNL2 ZNF638 SNU13 RRP7A HCFC2 PRRC2A FOXC1 FLNB LIMA1 CDC42BPA NUDT21 FNBP4 TBL3 AKAP8L MYL12A CEBPZ OSBPL3 TOP2A TOP2B | 1.12e-05 | 807 | 253 | 26 | int:DOT1L |
| Interaction | PSG8 interactions | 1.15e-05 | 41 | 253 | 6 | int:PSG8 | |
| Interaction | LRRC31 interactions | GBF1 NCL SLC25A3 XRN1 PRRC2A FLNB CDC42BPA COPA DDX60 LAMC1 MYOF TOP2B | 1.15e-05 | 205 | 253 | 12 | int:LRRC31 |
| Interaction | EFTUD2 interactions | ASXL1 ABCF1 ILF3 EIF4A3 SMC1A RPS15 KIF4A MCM4 NCL SSB ITGA4 MECP2 SLC25A3 TXNL1 DDX54 GNL2 ZNF638 SNU13 PRRC2A PUS7 PTCD3 FLNB COPA NUDT21 FNBP4 RANBP9 CCT7 AHCYL2 NCAPH RAD50 MYL12A SEC24C CEBPZ CHEK2 MACF1 MRPL41 TOP2A TOP2B | 1.23e-05 | 1449 | 253 | 38 | int:EFTUD2 |
| Interaction | RPS6 interactions | ILF3 EIF4A3 RPS15 NCL SSB ITGA4 MECP2 BLM TXNL1 CACTIN DDX54 XRN1 GNL2 SNU13 MINDY4 SDHA PTCD3 RNF213 APOB NCAPH TBL3 AKAP8L CEBPZ STEEP1 MRPL9 TOP2A TOP2B | 1.59e-05 | 874 | 253 | 27 | int:RPS6 |
| Interaction | H3C3 interactions | RNF168 SMC1A KIF4A ITGA4 MECP2 DHX8 BLM CACTIN BRPF1 RAD54B DDX54 GNL2 CDYL TAF1 FOXC1 ZNF8 STEEP1 TOP2A TOP2B | 1.73e-05 | 495 | 253 | 19 | int:H3C3 |
| Interaction | SNRNP70 interactions | ABCF1 ILF3 EIF4A3 RPS15 NCL SSB ITGA4 ARHGEF16 MECP2 DHX8 CACTIN DDX54 GNL2 ZNF638 SNU13 PRRC2A FOXC1 PTCD3 CDC42BPA COPA NUDT21 AKAP8L MYL12A PAXIP1 MRPL41 MRPL9 TOP2A TOP2B SP7 | 1.82e-05 | 984 | 253 | 29 | int:SNRNP70 |
| Interaction | CENPA interactions | ORC3 KIF4A MCM4 MECP2 BLM TXNL1 CACTIN BRPF1 DDX54 GNL2 TAF1 PARP2 CEBPZ STEEP1 TOP2A TOP2B | 2.44e-05 | 377 | 253 | 16 | int:CENPA |
| Interaction | BTNL8 interactions | 2.57e-05 | 47 | 253 | 6 | int:BTNL8 | |
| Interaction | RPS24 interactions | ILF3 EIF4A3 RPS15 NCL SSB ITGA4 BLM TXNL1 DDX54 GNL2 SNU13 RRP7A CCT7 NCAPH TBL3 CEBPZ STEEP1 TOP2A TOP2B | 4.27e-05 | 529 | 253 | 19 | int:RPS24 |
| Interaction | H2BC8 interactions | ORC3 KIF4A ITGA4 MECP2 DHX8 BLM CACTIN BRPF1 GNL2 CDYL SDHA PUS7 FOXC1 VRK2 EP400 PARP2 ZNF8 STEEP1 TOP2A TOP2B | 4.31e-05 | 576 | 253 | 20 | int:H2BC8 |
| Interaction | YWHAE interactions | APH1B CDK18 GBF1 ILF3 EIF4A3 NCL SSB ITGA4 ARHGEF16 MAP3K5 PTPN14 DDX54 ZNF638 SYN2 MINDY4 FERMT2 PRRC2A SDHA RASAL2 FOXC1 ARAP2 LIMA1 CDC42BPA PNLIP MAP7D3 COPA USP43 PTPDC1 OSBPL3 MOB3C MACF1 TOP2A OTOG | 4.72e-05 | 1256 | 253 | 33 | int:YWHAE |
| Interaction | HECTD1 interactions | ABCF1 PNMA1 EIF4A3 SMC1A KIF4A NCL SSB DHX8 BLM PTPN14 DDX54 XRN1 GNL2 SNU13 RRP7A TAF1 PRRC2A MAP7D3 COPA CCT7 NCAPH MTPAP TBL3 AKAP8L CEBPZ MACF1 TOP2A TOP2B | 4.77e-05 | 984 | 253 | 28 | int:HECTD1 |
| Interaction | POLR1G interactions | SMC1A NCL MECP2 BLM CACTIN CAMKV BRPF1 DDX54 GNL2 TAF1 EP400 TBL3 RAD50 CEBPZ STEEP1 CHEK2 TOP2A TOP2B | 4.98e-05 | 489 | 253 | 18 | int:POLR1G |
| Interaction | RPL31 interactions | ILF3 EIF4A3 RPS15 NCL SSB DHX8 BLM TXNL1 DDX54 GNL2 SNU13 RRP7A TAF1 VRK2 RANBP9 NCAPH TBL3 CEBPZ STEEP1 MACF1 TOP2A TOP2B | 5.12e-05 | 680 | 253 | 22 | int:RPL31 |
| Interaction | H2BC9 interactions | ABCF1 EIF4A3 SMC1A HPSE2 SSB ITGA4 NEB HPSE OTOF DNAH6 PRRC2A FRAS1 DUOX2 CEBPZ KIF4B RP1 TOP2A | 5.26e-05 | 446 | 253 | 17 | int:H2BC9 |
| Interaction | ZNF330 interactions | ILF3 ORC3 KIF4A NCL SSB MECP2 BLM BRPF1 DDX54 GNL2 RRP7A TAF1 PUS7 ZNF8 CEBPZ TOP2A TOP2B | 5.26e-05 | 446 | 253 | 17 | int:ZNF330 |
| Interaction | CDC42 interactions | RPS15 ITGA6 NCL SSB ARHGEF16 ITGB1 MECP2 ITGB8 SLC25A3 TXNL1 FAT1 PTPN14 GLS DDX54 FERMT2 SNX9 SDHA RASAL2 ARAP2 TRAF7 LIMA1 VRK2 CDC42BPA COPA DYNC2H1 NUDT21 MPZL1 AHCYL2 MTPAP MYOF SEC24C CEBPZ LNPEP TOP2B | 5.56e-05 | 1323 | 253 | 34 | int:CDC42 |
| Interaction | STIP1 interactions | GBF1 ILF3 EIF4A3 SMC1A MCM4 PSMD8 SSB ITGA4 DYRK4 NEB ARHGEF16 HPSE SLC25A3 PTPN14 FLNB TBC1D15 COPA NUDT21 DNAJC16 DDX60 CCT7 TBL3 RAD50 MYL12A SEC24C MOB3C HAO2 TOP2B | 6.98e-05 | 1006 | 253 | 28 | int:STIP1 |
| Interaction | H2BC21 interactions | ILF3 RNF168 KIF4A MCM4 NCL SSB NEB MECP2 BLM OTOF BRPF1 ZNF638 CDYL HCFC2 PRRC2A EP400 PARP2 FNBP4 DUOX2 RAD50 TOP2A TOP2B | 7.20e-05 | 696 | 253 | 22 | int:H2BC21 |
| Interaction | NR2C2 interactions | ABCF1 ILF3 ORC3 EIF4A3 SMC1A RPS15 MCM4 NCL SSB HPSE SLC25A3 TXNL1 CACTIN DDX54 GNL2 IQSEC1 SNU13 RRP7A CDYL SDHA PTCD3 VRK2 EP400 COPA NUDT21 PARP2 AGPS NCAPH MTPAP TBL3 AKAP8L SEC24C CEBPZ TOP2A TOP2B | 7.77e-05 | 1403 | 253 | 35 | int:NR2C2 |
| Interaction | GML interactions | 8.65e-05 | 58 | 253 | 6 | int:GML | |
| Interaction | WDR25 interactions | 8.65e-05 | 58 | 253 | 6 | int:WDR25 | |
| Interaction | H1-4 interactions | ASXL1 ILF3 RPS15 NCK1 NCL SSB NEB DHX8 DDX54 XRN1 GNL2 ZNF638 FER1L5 LIMA1 ITGA8 NCAPH CEBPZ TCEANC2 MACF1 MRPL9 TOP2B | 8.84e-05 | 656 | 253 | 21 | int:H1-4 |
| Interaction | RPL18 interactions | ILF3 EIF4A3 RPS15 NCL SSB ITGA4 MECP2 DDX54 GNL2 SNU13 RRP7A NUDT21 DNAJC16 NCAPH MYL12A CEBPZ MRPL9 TOP2A | 8.93e-05 | 512 | 253 | 18 | int:RPL18 |
| Interaction | ST8SIA4 interactions | 9.00e-05 | 84 | 253 | 7 | int:ST8SIA4 | |
| Interaction | TEX101 interactions | ITGA6 PSMD8 SSB ITGB1 SLC25A3 SNU13 MGAM FLNB COPA APCS CCT7 NDRG4 | 9.72e-05 | 255 | 253 | 12 | int:TEX101 |
| Interaction | RNF2 interactions | ASXL1 ABCF1 ILF3 EIF4A3 SMC1A RPS15 NCL SSB IQSEC1 ZNF638 SNU13 RRP7A PTCD3 FLNB LIMA1 EP400 COPA NUDT21 NCAPH AKAP8L RAD50 CEBPZ PAXIP1 TOP2A SP7 | 9.87e-05 | 866 | 253 | 25 | int:RNF2 |
| Interaction | WDR76 interactions | IMPDH1 ORC3 EIF4A3 SMC1A MCM4 SLC25A3 TAF1 FLNB FRAS1 EP400 NUDT21 PARP2 LAMC1 CCT7 NCAPH | 1.08e-04 | 383 | 253 | 15 | int:WDR76 |
| Interaction | SRPK2 interactions | GBF1 ILF3 EIF4A3 MCM4 NCL DHX8 CACTIN OTOF DDX54 GNL2 ZNF638 CPLANE1 DNAH6 PRRC2A PTCD3 NUDT21 CEBPZ CHEK2 TCEANC2 MACF1 TOP2A TOP2B | 1.11e-04 | 717 | 253 | 22 | int:SRPK2 |
| Interaction | H2BC10 interactions | 1.15e-04 | 61 | 253 | 6 | int:H2BC10 | |
| Interaction | SCARNA22 interactions | 1.23e-04 | 118 | 253 | 8 | int:SCARNA22 | |
| Interaction | CSNK2B interactions | SSB ITGA4 MECP2 BLM CACTIN CAMKV BRPF1 DDX54 CDYL HCFC2 SNX9 SDHA CDC42BPA EP400 USP43 PAXIP1 CHEK2 TOP2A TOP2B SP7 | 1.31e-04 | 625 | 253 | 20 | int:CSNK2B |
| Interaction | HMGN5 interactions | 1.46e-04 | 154 | 253 | 9 | int:HMGN5 | |
| Interaction | LGALS9 interactions | ILF3 ATP7A EIF4A3 CD109 NCL ITGA4 ITGB1 SLC25A3 FLNB TBC1D15 COPA MPZL1 LAMC1 CCT7 CNNM4 SEC24C LNPEP TOP2A TOP2B | 1.71e-04 | 588 | 253 | 19 | int:LGALS9 |
| Interaction | MECP2 interactions | ABCF1 ILF3 EIF4A3 SMC1A NCL ARHGEF16 MECP2 DHX8 BLM SLC25A3 TXNL1 DDX54 GNL2 IQSEC1 ZNF638 RRP7A FOXC1 PTCD3 CDC42BPA EP400 COPA NUDT21 FNBP4 AGPS AKAP8L ZNF8 MYL12A SEC24C CEBPZ MACF1 MRPL41 TOP2B | 1.72e-04 | 1287 | 253 | 32 | int:MECP2 |
| Interaction | H2AC17 interactions | 1.77e-04 | 232 | 253 | 11 | int:H2AC17 | |
| Interaction | H3C1 interactions | SMC1A KIF4A MCM4 PSMD8 SSB ITGA4 NEB MECP2 BLM CACTIN BRPF1 DDX54 GNL2 ZNF638 CDYL TAF1 PUS7 PTCD3 DYNC2H1 PARP2 RAD50 STEEP1 PAXIP1 TOP2A TOP2B | 1.82e-04 | 901 | 253 | 25 | int:H3C1 |
| Interaction | PTCH1 interactions | ILF3 ITGA6 PSMD8 ITGA4 GALNT18 PRRC2A ITGA8 ACAD10 AKAP8L RAD50 CNNM4 MARCHF5 | 1.84e-04 | 273 | 253 | 12 | int:PTCH1 |
| Interaction | CDC5L interactions | ILF3 ORC3 EIF4A3 SMC1A RPS15 KIF4A MCM4 NCL MECP2 DHX8 CACTIN GNL2 ZNF638 COPA NUDT21 CCT7 NCAPH RAD50 SEC24C STEEP1 PAXIP1 MOB3C MACF1 TOP2A | 2.07e-04 | 855 | 253 | 24 | int:CDC5L |
| Interaction | BLM interactions | EIF4A3 SMC1A MECP2 DHX8 BLM GNL2 CILK1 RAD50 PAXIP1 CHEK2 TOP2A | 2.29e-04 | 239 | 253 | 11 | int:BLM |
| Interaction | H2BC12 interactions | ASXL1 ABCF1 EIF4A3 MCM4 NCL SSB NEB XRN1 ZNF638 PRRC2A DUOX2 TOP2A TOP2B | 2.30e-04 | 322 | 253 | 13 | int:H2BC12 |
| Interaction | RPL14 interactions | ILF3 RPS15 NCL SSB ITGA4 MECP2 DHX8 BLM DDX54 XRN1 GNL2 MINDY4 RANBP9 NCAPH CEBPZ MOB3C MACF1 TOP2A | 2.37e-04 | 554 | 253 | 18 | int:RPL14 |
| Interaction | CCDC8 interactions | ABCF1 ILF3 SMC1A MCM4 NCL ITGB1 SLC25A3 FOXC1 FLNB TBC1D15 LIMA1 EP400 COPA MPZL1 LAMC1 CCT7 APOB AGPS MACF1 TOP2A | 2.48e-04 | 656 | 253 | 20 | int:CCDC8 |
| Interaction | NPM1 interactions | ASXL1 ILF3 RPS15 NCL SSB ITGA4 NEB ITGB1 MECP2 SLC25A3 CFAP54 PTPN14 DDX54 GNL2 ZNF638 MINDY4 PRRC2A PTCD3 FLNB NUDT21 PARP2 NCAPH MTPAP TBL3 RAD50 CEBPZ MRPL41 RP1 TOP2A TOP2B | 2.57e-04 | 1201 | 253 | 30 | int:NPM1 |
| Interaction | NAA40 interactions | ABCF1 ILF3 KIF4A MCM4 NCL MECP2 SLC25A3 XRN1 GNL2 ZNF638 FERMT2 SNX9 PRRC2A PUS7 LIMA1 MAP7D3 EP400 PARP2 CCT7 NCAPH RAD50 STEEP1 NCOA7 MACF1 TOP2A TOP2B | 2.63e-04 | 978 | 253 | 26 | int:NAA40 |
| Interaction | HSF1 interactions | ABCF1 ILF3 EIF4A3 SMC1A KIF4A MCM4 NCL SLC25A3 TAF1 CPLANE1 TBC1D15 MAP7D3 EP400 COPA NCAPH RAD50 MYOF SEC24C TOP2A | 2.66e-04 | 609 | 253 | 19 | int:HSF1 |
| Interaction | RAD50 interactions | ILF3 MCM8 SMC1A NCK1 NCL ZNF227 BLM MINDY4 NUDT21 CCT7 RAD50 PAXIP1 CHEK2 TOP2B | 2.67e-04 | 371 | 253 | 14 | int:RAD50 |
| Interaction | CMA1 interactions | 2.70e-04 | 46 | 253 | 5 | int:CMA1 | |
| Interaction | LMNB1 interactions | ILF3 MCM8 MCM4 SSB ITGA4 ITGB1 MECP2 DDX54 SNU13 SDHA FOXC1 VRK2 DNAJC16 RANBP9 NCAPH MTPAP MARCHF5 STEEP1 CHEK2 | 2.71e-04 | 610 | 253 | 19 | int:LMNB1 |
| Interaction | WEE1 interactions | 2.81e-04 | 133 | 253 | 8 | int:WEE1 | |
| Interaction | MCM6 interactions | MCM8 SMC1A MCM4 ITGA4 DUSP22 SCNM1 SDHA FOXC1 COPA NCAPH PAXIP1 MOB3C | 2.91e-04 | 287 | 253 | 12 | int:MCM6 |
| Interaction | MCM5 interactions | CFH ILF3 MCM8 ORC3 MCM4 NCL ITGA4 SDHA PUS7 FOXC1 FLNB RAD50 CHEK2 MOB3C TOP2A | 2.92e-04 | 420 | 253 | 15 | int:MCM5 |
| Interaction | PIK3R5 interactions | 2.99e-04 | 11 | 253 | 3 | int:PIK3R5 | |
| Interaction | TAFAZZIN interactions | CD109 VWDE GALNT18 FAT1 GLS TXNDC16 FRAS1 ITGA8 NHLRC3 ACAD10 | 3.00e-04 | 207 | 253 | 10 | int:TAFAZZIN |
| Interaction | DCAF13 interactions | IMPDH1 RPS15 MECP2 GNL2 SNU13 CCT7 TBL3 CEBPZ PAXIP1 CHEK2 MRPL9 | 3.04e-04 | 247 | 253 | 11 | int:DCAF13 |
| Interaction | H2AB3 interactions | 3.26e-04 | 136 | 253 | 8 | int:H2AB3 | |
| Interaction | CHD4 interactions | ABCF1 ILF3 EIF4A3 SMC1A RPS15 MCM4 NCL ITGA4 MECP2 DHX8 SLC25A3 DDX54 XRN1 GNL2 ZNF638 SNU13 FOXC1 FNBP4 USP43 NCAPH TBL3 AKAP8L MOB3C TOP2A TOP2B | 3.34e-04 | 938 | 253 | 25 | int:CHD4 |
| Interaction | PRPF8 interactions | ASXL1 ABCF1 ILF3 EIF4A3 SMC1A NCL ITGA4 ITGB1 MECP2 DHX8 SLC25A3 TXNL1 CACTIN GLS MINDY4 FOXC1 LIMA1 NUDT21 RANBP9 CCT7 PAXIP1 TOP2A | 3.34e-04 | 776 | 253 | 22 | int:PRPF8 |
| Interaction | SCGB1D4 interactions | 3.39e-04 | 27 | 253 | 4 | int:SCGB1D4 | |
| Interaction | SRP9 interactions | CFH EIF4A3 RPS15 NCL SSB ITGA4 MECP2 BLM DDX54 GNL2 PRRC2A SGCD PAXIP1 MOB3C TOP2B | 3.48e-04 | 427 | 253 | 15 | int:SRP9 |
| Interaction | RAB35 interactions | ATP7A RPS15 ITGA6 ITGB1 MECP2 PTPN14 DDX54 FERMT2 RASAL2 VRK2 CDC42BPA MPZL1 AHCYL2 CNNM4 LNPEP MOB3C NCOA7 MACF1 | 3.55e-04 | 573 | 253 | 18 | int:RAB35 |
| Interaction | PPIA interactions | ASXL1 ILF3 EIF4A3 PSMD8 ITGA4 ITGB1 MECP2 DHX8 BLM SDHA PUS7 VRK2 EP400 DYNC2H1 NUDT21 DDX60 RANBP9 ANKRD50 RAD50 STEEP1 PAXIP1 MACF1 MAP2K6 TOP2A | 3.61e-04 | 888 | 253 | 24 | int:PPIA |
| Interaction | ODAPH interactions | 3.64e-04 | 49 | 253 | 5 | int:ODAPH | |
| Interaction | SMC5 interactions | ILF3 EIF4A3 SMC1A KIF4A MCM4 NCL MECP2 BLM SLC25A3 GNL2 ZNF638 SNU13 TAF1 PRRC2A FOXC1 MAP7D3 EP400 NUDT21 FNBP4 TBL3 RAD50 MYL12A CEBPZ STEEP1 TOP2A TOP2B | 3.70e-04 | 1000 | 253 | 26 | int:SMC5 |
| Interaction | MEX3A interactions | ASXL1 MCM4 NCL FAT1 PTPN14 BRPF1 PRRC2A FLNB COPA LAMC1 CDCP1 MYOF MACF1 TOP2A | 3.77e-04 | 384 | 253 | 14 | int:MEX3A |
| Interaction | LRRC39 interactions | 3.96e-04 | 12 | 253 | 3 | int:LRRC39 | |
| Interaction | DDX23 interactions | MCM4 NCL MECP2 DHX8 CACTIN BRPF1 DDX54 GNL2 ZNF638 TAF1 FOXC1 NUDT21 CEBPZ PAXIP1 TOP2A TOP2B | 3.97e-04 | 480 | 253 | 16 | int:DDX23 |
| GeneFamily | Ferlin family | 1.49e-05 | 6 | 166 | 3 | 828 | |
| GeneFamily | Synaptotagmins | 4.70e-04 | 17 | 166 | 3 | 765 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.60e-04 | 18 | 166 | 3 | 1160 | |
| GeneFamily | Topoisomerases | 1.23e-03 | 6 | 166 | 2 | 1050 | |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | ASXL1 ILF3 SMC1A MCM4 NCK1 ITGA4 BLM FAT1 NUDT21 FNBP4 AGPS NCAPH PAXIP1 CHEK2 MAP2K6 MRPL9 TOP2A | 1.09e-06 | 426 | 255 | 17 | M9516 |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 1.13e-06 | 139 | 255 | 10 | M6754 | |
| Coexpression | GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN | ASXL1 NEB NRN1 ITGB8 SNX9 PARP2 LAMC1 AHCYL2 MCTP1 OSBPL3 ENTPD1 | 1.57e-06 | 179 | 255 | 11 | M8900 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | KIF4A ANO5 ATP9B BLM C5 MAP7D3 NCAPH EDNRB PRELP CHEK2 TOP2A | 2.80e-06 | 190 | 255 | 11 | M761 |
| Coexpression | BENPORATH_ES_1 | ILF3 ZGRF1 CYP26A1 KIF4A MCM4 SSB CAMKV RAD54B PUS7 NUDT21 NCAPH GDF3 CEBPZ CHEK2 | 2.33e-05 | 379 | 255 | 14 | M1871 |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN | 2.72e-05 | 199 | 255 | 10 | M5382 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP | C5orf22 DENND2D NRN1 ITGB1 SNX9 ARAP2 VRK2 RAD50 SERPINC1 FILIP1L | 2.72e-05 | 199 | 255 | 10 | M5604 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.86e-05 | 90 | 255 | 7 | M39250 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 3.14e-05 | 162 | 255 | 9 | M45037 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CFH PGBD1 THSD1 CSMD3 FERMT2 MMP19 MAP7D3 ABI3BP DYNC2H1 SGCD LAMC1 EDNRB LRRN3 MCTP1 EGFLAM FILIP1L | 3.97e-05 | 505 | 255 | 16 | M39167 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | PDE6B ITGA6 ITGB1 SEMA6D SNX9 ARAP2 RANBP9 XDH AHCYL2 AGPS MACF1 | 6.25e-05 | 265 | 255 | 11 | M1684 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | C5orf22 IMPDH1 MCM8 MCM4 PSMD8 ITGB1 HSPA13 PTPN14 GNL2 FERMT2 RASAL2 DYNC2H1 NUDT21 ARMC9 AGPS CEBPZ LNPEP OSBPL3 | 6.68e-05 | 644 | 255 | 18 | M10501 |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 7.14e-05 | 180 | 255 | 9 | M2961 | |
| Coexpression | NABA_CORE_MATRISOME | GLDN VWDE OTOGL FRAS1 ABI3BP LAMC1 OMD PRELP SLIT3 EGFLAM OTOG | 7.39e-05 | 270 | 255 | 11 | MM17057 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | PDE6B ITGA6 ITGB1 SEMA6D SNX9 ARAP2 RANBP9 XDH AHCYL2 AGPS MACF1 | 7.89e-05 | 272 | 255 | 11 | MM1027 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ANO5 NEB CSMD3 FAT1 OTOGL MGAM FRAS1 APOB LOXHD1 UNC13C OTOG | 8.54e-10 | 184 | 257 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ANO5 NEB CSMD3 FAT1 OTOGL MGAM FRAS1 APOB LOXHD1 UNC13C OTOG | 8.54e-10 | 184 | 257 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ANO5 NEB CSMD3 FAT1 OTOGL MGAM FRAS1 APOB LOXHD1 UNC13C OTOG | 8.54e-10 | 184 | 257 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | BOC ABCA4 GALNT18 ITGB8 PTPN14 SLC44A5 DMGDH FRAS1 SYT10 LNPEP OSBPL3 RP1 | 1.03e-09 | 187 | 257 | 12 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | CFH CD109 GALNT18 FAT1 PTPN14 FERMT2 CDC42BPA ABI3BP LAMC1 MYOF PRELP SLIT3 | 1.97e-09 | 198 | 257 | 12 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | ITGA4 EBF2 PIK3CG MMP16 DMGDH ABI3BP MED13L OMD EDNRB SYT16 PCDHGA12 | 1.08e-08 | 184 | 257 | 11 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | GLS RASAL2 FLNB NTF3 SGCD ITGA8 MYOF ENTPD1 SLIT3 MACF1 UNC13C | 1.35e-08 | 188 | 257 | 11 | 34e1b074a3995aa46ab194eb45115d76d1a5514d |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | BOC ABCA4 GALNT18 ITGB8 PTPN14 SLC44A5 FRAS1 ABI3BP LNPEP OSBPL3 RP1 | 1.51e-08 | 190 | 257 | 11 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | CFH HPSE2 SEMA6D FLNB ABI3BP NTF3 SGCD LAMC1 EDNRB SLIT3 FILIP1L | 2.43e-08 | 199 | 257 | 11 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | BOC GALNT18 ITGB8 FAT1 CFAP54 PTPN14 SLC44A5 ABI3BP GRM5 SYT10 | 1.12e-07 | 182 | 257 | 10 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.31e-07 | 185 | 257 | 10 | 56c7a0dbf141728ac76b8c90af197719942ca67c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | GALNT18 ITGB8 FAT1 CFAP54 PTPN14 SLC44A5 DNAH6 ARSJ ABI3BP GRM5 | 1.37e-07 | 186 | 257 | 10 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.60e-07 | 189 | 257 | 10 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CD109 ITGA4 THSD1 GALNT18 RASAL2 FRAS1 CDC42BPA EDNRB MCTP1 EGFLAM | 1.68e-07 | 190 | 257 | 10 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-07 | 192 | 257 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-07 | 193 | 257 | 10 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-07 | 194 | 257 | 10 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.34e-07 | 197 | 257 | 10 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.46e-07 | 198 | 257 | 10 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | CD109 SCEL ITGA4 THSD1 FRAS1 ANKRD50 ENTPD1 MACF1 EGFLAM NDRG4 | 2.57e-07 | 199 | 257 | 10 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.57e-07 | 199 | 257 | 10 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ITGA6 GBP3 ITGB1 GALNT18 FLNB RNF213 SH2B2 MCTP1 MACF1 FILIP1L | 2.70e-07 | 200 | 257 | 10 | 2d07237022b409c4fac6fcf99b68c8affb3007cd |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.70e-07 | 200 | 257 | 10 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | GBP3 ITGA4 THSD1 GALNT18 XRN1 PARP15 DDX60 RNF213 EDNRB MCTP1 | 2.70e-07 | 200 | 257 | 10 | 89821a264e872ed53e08e9d3609d5cc5c314503e |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | GBP3 ITGA4 THSD1 GALNT18 FERMT2 RNF213 ANKRD50 EDNRB MCTP1 MACF1 | 2.70e-07 | 200 | 257 | 10 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.70e-07 | 200 | 257 | 10 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | ITGA6 GBP3 GALNT18 SEMA6D FLNB SH2B2 MCTP1 ENTPD1 NCOA7 FILIP1L | 2.70e-07 | 200 | 257 | 10 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-07 | 169 | 257 | 9 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.00e-07 | 171 | 257 | 9 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.72e-07 | 173 | 257 | 9 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Sla|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-06 | 132 | 257 | 8 | ddebc0b233fdbb73ceb70187945bbed8fd273f2a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 179 | 257 | 9 | 820289f14ecf165758529c236bb220bb1a744f02 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_GPR21|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-06 | 179 | 257 | 9 | e5f781d35449628a7f356d71e26231dd63482eec | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-06 | 179 | 257 | 9 | 55bc69f107fc710db7617c428575792adfdbbcc1 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_SCP_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-06 | 181 | 257 | 9 | fad7ba168f541ac9d04edebc206f191e48bb7e99 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 182 | 257 | 9 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-06 | 183 | 257 | 9 | af8d86f15a549064530d94bd47081daf59d58ecd | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 184 | 257 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.35e-06 | 185 | 257 | 9 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 185 | 257 | 9 | 1ecfca049c0c1110fd1b2256db7cb7abda6afb04 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-06 | 185 | 257 | 9 | b6df1412b579d40ed5df806f9c54bd1fbb9a1e15 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.35e-06 | 185 | 257 | 9 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-06 | 186 | 257 | 9 | 3113c85d0ac5fc46532c19b1bb71f34b985e1276 | |
| ToppCell | PCW_07-8.5-Neuronal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.41e-06 | 186 | 257 | 9 | 7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.41e-06 | 186 | 257 | 9 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.41e-06 | 186 | 257 | 9 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-06 | 187 | 257 | 9 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-06 | 187 | 257 | 9 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-06 | 187 | 257 | 9 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-06 | 187 | 257 | 9 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-06 | 189 | 257 | 9 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.61e-06 | 189 | 257 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.61e-06 | 189 | 257 | 9 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 190 | 257 | 9 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.68e-06 | 190 | 257 | 9 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-06 | 191 | 257 | 9 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.76e-06 | 191 | 257 | 9 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.76e-06 | 191 | 257 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.76e-06 | 191 | 257 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 192 | 257 | 9 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 192 | 257 | 9 | 992d08092edbc68c47b945deb8708379738c239a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-06 | 193 | 257 | 9 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 193 | 257 | 9 | 263d185af6ed80e639f864e4966268e0862c61dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 193 | 257 | 9 | 80e058c224749b5fe0ba3e944b48317c2371cb63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 193 | 257 | 9 | b991fbbb4618401624f0b3045f0e81a606d3a763 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.91e-06 | 193 | 257 | 9 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 194 | 257 | 9 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | Cerebellum-Endothelial|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.08e-06 | 195 | 257 | 9 | 2192fd9b4682054776f0716933aed5a4a9412657 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-06 | 195 | 257 | 9 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-06 | 195 | 257 | 9 | 43d372373367b71243c6ea958aedccde4478618f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-06 | 195 | 257 | 9 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.17e-06 | 196 | 257 | 9 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-06 | 196 | 257 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-06 | 196 | 257 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 2.27e-06 | 197 | 257 | 9 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-06 | 197 | 257 | 9 | 5a71e859ebe734fc70a056807b07d99fa867c687 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.27e-06 | 197 | 257 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.36e-06 | 198 | 257 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-06 | 198 | 257 | 9 | 63f7d25201613bd3404c28fb936954190bca91d3 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-06 | 198 | 257 | 9 | a73534b6ca202c277a70a52281d5b97a3e6cb8ef | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-06 | 198 | 257 | 9 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-06 | 198 | 257 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-06 | 198 | 257 | 9 | d1e1bdd36c84e1bac21ba137f018defe98456a8c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-06 | 198 | 257 | 9 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-06 | 198 | 257 | 9 | 8602a518b5913625b1dd3cbc3c7e6efde0d5d942 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.40e-06 | 148 | 257 | 8 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | stromal_cell-stromal_cell|World / Lineage and Cell class | 2.46e-06 | 199 | 257 | 9 | 74262363a34da3a1eb55ab375fd61ddd7bb39b23 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.46e-06 | 199 | 257 | 9 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | stromal_cell|World / Lineage and Cell class | 2.46e-06 | 199 | 257 | 9 | 507a82d0529b5b1fa5aebcfe43db53f0b6e3f8f0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-06 | 199 | 257 | 9 | 0d63da0afa93741c37609d879941de202d9ac86c | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.46e-06 | 199 | 257 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.46e-06 | 199 | 257 | 9 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 200 | 257 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.56e-06 | 200 | 257 | 9 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 200 | 257 | 9 | c5e051f1aac8dda376c342a9932785a23450e073 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 200 | 257 | 9 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 200 | 257 | 9 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.56e-06 | 200 | 257 | 9 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.56e-06 | 200 | 257 | 9 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.56e-06 | 200 | 257 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | ACADS SMC1A CYP26A1 CACTIN GLS TMUB2 AHCYL2 ATP8B2 ZNF8 MYOF DZANK1 MAP2K6 | 1.84e-06 | 191 | 256 | 12 | 3890_DN |
| Disease | potassium voltage-gated channel subfamily E regulatory beta subunit 5 measurement | 2.30e-06 | 4 | 247 | 3 | EFO_0801902 | |
| Disease | Disorder of eye | 1.31e-05 | 212 | 247 | 10 | C0015397 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.98e-05 | 7 | 247 | 3 | DOID:11724 (implicated_via_orthology) | |
| Disease | Retinitis pigmentosa | 3.73e-05 | 74 | 247 | 6 | cv:C0035334 | |
| Disease | factor VIII measurement, coronary artery disease | 4.81e-05 | 113 | 247 | 7 | EFO_0001645, EFO_0004630 | |
| Disease | Short Stature, CTCAE | 6.66e-05 | 10 | 247 | 3 | C2919142 | |
| Disease | Short stature | 6.66e-05 | 10 | 247 | 3 | C0349588 | |
| Disease | B cell deficiency (implicated_via_orthology) | 6.98e-05 | 2 | 247 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | coronary artery disease | ANKRD31 WBP2 TDRD15 CDK18 CD109 VWDE GLS C5 FOXC1 MAP7D3 DYNC2H1 SGCD USP43 RNF213 DUOX2 LAMC1 APOB ACAD10 ANKRD50 AP4E1 LNPEP KIF4B RP1 | 1.92e-04 | 1194 | 247 | 23 | EFO_0001645 |
| Disease | C5a anaphylatoxin measurement | 2.08e-04 | 3 | 247 | 2 | EFO_0020208 | |
| Disease | brother of CDO measurement | 2.08e-04 | 3 | 247 | 2 | EFO_0020194 | |
| Disease | prolow-density lipoprotein receptor-related protein 1 measurement | 2.08e-04 | 3 | 247 | 2 | EFO_0801929 | |
| Disease | low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor | 2.45e-04 | 15 | 247 | 3 | EFO_0004611, EFO_0005658 | |
| Disease | Retinitis Pigmentosa | 2.48e-04 | 104 | 247 | 6 | C0035334 | |
| Disease | calcium measurement | CFH ANKRD31 MFSD6 CD109 HPSE2 SYN2 FER1L5 PARP15 ARSJ PDCL2 NCAPH CNNM4 GPCPD1 MACF1 MAP2K6 | 2.92e-04 | 628 | 247 | 15 | EFO_0004838 |
| Disease | Heart Decompensation | 3.36e-04 | 110 | 247 | 6 | C1961112 | |
| Disease | Myocardial Failure | 3.36e-04 | 110 | 247 | 6 | C1959583 | |
| Disease | Congestive heart failure | 3.36e-04 | 110 | 247 | 6 | C0018802 | |
| Disease | Heart failure | 3.36e-04 | 110 | 247 | 6 | C0018801 | |
| Disease | Left-Sided Heart Failure | 3.36e-04 | 110 | 247 | 6 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 3.36e-04 | 110 | 247 | 6 | C0235527 | |
| Disease | response to tenofovir, creatinine clearance measurement | 3.70e-04 | 112 | 247 | 6 | EFO_0007934, EFO_0009279 | |
| Disease | Intellectual Disability | EIF4A3 KIF4A MECP2 IQSEC1 TAF1 PUS7 MAP7D3 ARMC9 MED13L AP4E1 ENTPD1 MACF1 | 4.23e-04 | 447 | 247 | 12 | C3714756 |
| Disease | optic disc area measurement | 5.45e-04 | 45 | 247 | 4 | EFO_0006937 | |
| Disease | Retinal Dystrophy, Early Onset Severe | 6.86e-04 | 5 | 247 | 2 | C1858080 | |
| Disease | arecaidine measurement | 6.86e-04 | 5 | 247 | 2 | EFO_0801112 | |
| Disease | thrombospondin type-1 domain-containing protein 1 measurement | 6.86e-04 | 5 | 247 | 2 | EFO_0802131 | |
| Disease | Immunologic Deficiency Syndromes | 9.07e-04 | 23 | 247 | 3 | C0021051 | |
| Disease | galectin-7 measurement | 1.02e-03 | 6 | 247 | 2 | EFO_0022034 | |
| Disease | Congenital hypothyroidism | 1.02e-03 | 6 | 247 | 2 | cv:C0010308 | |
| Disease | Dwarfism | 1.16e-03 | 25 | 247 | 3 | C0013336 | |
| Disease | vascular cell adhesion protein 1 measurement | 1.43e-03 | 7 | 247 | 2 | EFO_0020846 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 1.46e-03 | 27 | 247 | 3 | EFO_0022238 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.49e-03 | 99 | 247 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | pulse pressure measurement | CFH TDRD15 RPS15 PGBD1 DHX8 EBF2 ZNF638 SYT4 FERMT2 FER1L5 PTCD3 TRAF7 FLNB DYNC2H1 SGCD RNF213 ACAD10 MED13L OMD SYT10 SLIT3 NDRG4 FILIP1L | 1.55e-03 | 1392 | 247 | 23 | EFO_0005763 |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.70e-03 | 102 | 247 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | optic disc size measurement | 1.77e-03 | 205 | 247 | 7 | EFO_0004832 | |
| Disease | Malignant neoplasm of breast | BOC ABCA4 CD109 HPSE PTPN14 OTOF OTOGL PRRC2A RASAL2 FLNB DYNC2H1 APCS XDH EDNRB CNNM4 CHEK2 MACF1 MRPL9 TOP2A | 1.86e-03 | 1074 | 247 | 19 | C0006142 |
| Disease | Congenital Amaurosis of Retinal Origin | 1.89e-03 | 8 | 247 | 2 | C3540662 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 1.89e-03 | 8 | 247 | 2 | EFO_0020829 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.89e-03 | 8 | 247 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | poly(A) RNA polymerase, mitochondrial measurement | 1.89e-03 | 8 | 247 | 2 | EFO_0801893 | |
| Disease | rheumatoid arthritis | ILF3 MECP2 DUSP22 ITGB8 TXNDC16 C5 SFTPD NTF3 ANKRD50 GRM5 SYT16 | 1.90e-03 | 462 | 247 | 11 | EFO_0000685 |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 1.94e-03 | 63 | 247 | 4 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | vitamin D measurement | TDRD15 CYP26A1 EBF2 SERPINB11 APOB CYP2R1 KIF4B C1orf94 MRPL9 | 2.22e-03 | 336 | 247 | 9 | EFO_0004631 |
| Disease | Malignant tumor of colon | 2.28e-03 | 159 | 247 | 6 | C0007102 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.30e-03 | 66 | 247 | 4 | DOID:5844 (implicated_via_orthology) | |
| Disease | frontotemporal dementia | 2.40e-03 | 32 | 247 | 3 | MONDO_0017276 | |
| Disease | ectonucleoside triphosphate diphosphohydrolase 1 measurement | 2.42e-03 | 9 | 247 | 2 | EFO_0020342 | |
| Disease | Subarachnoid Hemorrhage | 2.42e-03 | 9 | 247 | 2 | C0038525 | |
| Disease | epilepsy (implicated_via_orthology) | 2.58e-03 | 163 | 247 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | R-6-hydroxywarfarin measurement | 2.76e-03 | 114 | 247 | 5 | EFO_0803327 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.86e-03 | 34 | 247 | 3 | EFO_0009926 | |
| Disease | myocardial infarction | 2.91e-03 | 350 | 247 | 9 | EFO_0000612 | |
| Disease | Fuchs endothelial corneal dystrophy | 3.00e-03 | 10 | 247 | 2 | Orphanet_98974 | |
| Disease | neutrophil count | ZNF266 GDAP2 NCK1 TSHB ITGA4 MAP3K5 PTPN14 IQSEC1 SYN2 FLNB LIMA1 CDC42BPA COPA DYNC2H1 MPZL1 TEX14 AP4E1 LNPEP CHEK2 UNC13C RP1 SP7 | 3.08e-03 | 1382 | 247 | 22 | EFO_0004833 |
| Disease | chronotype measurement | ILF3 SCEL SEMA6D CAMKV AK5 GLS VRK2 SGCD DNAJC16 FNBP4 TEX14 MED13L SYT10 SYT16 FEZF1 TMEM108 | 3.29e-03 | 882 | 247 | 16 | EFO_0008328 |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 3.65e-03 | 11 | 247 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 3.65e-03 | 11 | 247 | 2 | EFO_0801531 | |
| Disease | cytochrome p450 3a4 measurement | 3.65e-03 | 11 | 247 | 2 | EFO_0020303 | |
| Disease | NG-monomethyl-arginine measurement | 3.65e-03 | 11 | 247 | 2 | EFO_0010510 | |
| Disease | carnitine measurement | 3.84e-03 | 76 | 247 | 4 | EFO_0010469 | |
| Disease | Disproportionate short stature | 4.02e-03 | 77 | 247 | 4 | C0878659 | |
| Disease | urinary albumin to creatinine ratio | 4.09e-03 | 179 | 247 | 6 | EFO_0007778 | |
| Disease | angina pectoris | 4.10e-03 | 125 | 247 | 5 | EFO_0003913 | |
| Disease | Hirschsprung's disease (implicated_via_orthology) | 4.36e-03 | 12 | 247 | 2 | DOID:10487 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 4.36e-03 | 12 | 247 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | non-alcoholic steatohepatitis | 4.36e-03 | 12 | 247 | 2 | EFO_1001249 | |
| Disease | decanoylcarnitine measurement | 4.36e-03 | 12 | 247 | 2 | EFO_0021039 | |
| Disease | Major Depressive Disorder | 4.55e-03 | 243 | 247 | 7 | C1269683 | |
| Disease | free cholesterol in medium LDL measurement | 4.56e-03 | 40 | 247 | 3 | EFO_0022268 | |
| Disease | epilepsy | 4.89e-03 | 41 | 247 | 3 | EFO_0000474 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 4.89e-03 | 41 | 247 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | hair color | 4.89e-03 | 311 | 247 | 8 | EFO_0003924 | |
| Disease | response to selective serotonin reuptake inhibitor | 5.03e-03 | 82 | 247 | 4 | EFO_0005658 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 5.12e-03 | 13 | 247 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | ventricular enlargement measurement | 5.12e-03 | 13 | 247 | 2 | EFO_0010570 | |
| Disease | Congenital Hypothyroidism | 5.12e-03 | 13 | 247 | 2 | C0010308 | |
| Disease | uric acid measurement | RPS15 PTGR2 MINDY4 FRAS1 CDC42BPA DYNC2H1 DNAJC16 ACAD10 ANKRD50 MYOF PTPDC1 NCOA7 | 5.61e-03 | 610 | 247 | 12 | EFO_0004761 |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 5.94e-03 | 14 | 247 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Diabetic Neuralgia | 5.94e-03 | 14 | 247 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 5.94e-03 | 14 | 247 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 5.94e-03 | 14 | 247 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 5.94e-03 | 14 | 247 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 5.94e-03 | 14 | 247 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 5.94e-03 | 14 | 247 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 5.94e-03 | 14 | 247 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 5.94e-03 | 14 | 247 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 5.94e-03 | 14 | 247 | 2 | C0393835 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 5.94e-03 | 14 | 247 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 5.94e-03 | 14 | 247 | 2 | C0677776 | |
| Disease | thyroid stimulating hormone measurement | 6.11e-03 | 323 | 247 | 8 | EFO_0004748 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 6.35e-03 | 45 | 247 | 3 | EFO_0022236 | |
| Disease | unipolar depression | CFH MAK PGBD1 CSMD3 MAP3K5 EBF2 FAT1 SEMA6D ZNF638 SYT4 DNAH6 PRRC2A PARP15 VRK2 DYNC2H1 RNF213 GRM5 IHO1 KIF4B | 6.47e-03 | 1206 | 247 | 19 | EFO_0003761 |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 6.75e-03 | 46 | 247 | 3 | EFO_0005325, HP_0012735 | |
| Disease | low density lipoprotein triglyceride measurement | 6.82e-03 | 15 | 247 | 2 | EFO_0009946 | |
| Disease | response to statin, LDL cholesterol change measurement | 6.82e-03 | 15 | 247 | 2 | EFO_0007804, GO_0036273 | |
| Disease | Nephrosis | 6.82e-03 | 15 | 247 | 2 | C0027720 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.95e-03 | 200 | 247 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | visual epilepsy (biomarker_via_orthology) | 6.98e-03 | 90 | 247 | 4 | DOID:11832 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELYTGKILFPGKTNN | 881 | Q13523 | |
| QGSKFLGLTPEKSYQ | 216 | Q68DN1 | |
| DNKDGPTQKYLLIFG | 61 | Q8WW43 | |
| AKLKASRLFQPVQYG | 1456 | Q96L91 | |
| ITQNYKYPEGSLQEK | 431 | P16452 | |
| TFGYQGQKPLFKNLD | 631 | Q8NE71 | |
| KNDGQPTLYLKFQRE | 986 | Q8NEM8 | |
| RNKGLIFPLENYKEG | 541 | Q96N23 | |
| NYDDVKKNSGVLKPF | 741 | Q63HQ2 | |
| KQIFGNIKEAIYPLA | 621 | Q75V66 | |
| SNKGFPQENEIIKLY | 36 | Q9H7T0 | |
| YSIQTQPGKGIQLKA | 1126 | Q7Z408 | |
| IPAQGKREGKSFIYQ | 3296 | Q7Z407 | |
| FIGFQKKAYTSPENL | 1746 | P78363 | |
| SLYLGPILKFGSKEQ | 121 | P16219 | |
| SNYFVGAIQEIPKAK | 31 | O60513 | |
| LVFGAKEITYGNNKP | 101 | P10323 | |
| IFSLKEIQLQKDPGY | 441 | Q07002 | |
| KKTNKGPAVGIYNDN | 696 | Q9H5V8 | |
| LPEKYNTQVGLKGAQ | 1141 | Q2M3G0 | |
| KGSFKDDPQLYQEIQ | 206 | Q5VV41 | |
| DSVTKQPIAYEGQNK | 131 | Q9HAK2 | |
| QKYLKDLLGIQTTGP | 271 | Q6JQN1 | |
| VKEFKDQPSLLNGSY | 346 | Q6ZMI3 | |
| QGPIEIKETFKYINT | 91 | P24530 | |
| EPSKILSGNKFQDRY | 1446 | Q8WZ64 | |
| KLQIEGSDPSFNYKK | 1411 | Q9ULJ7 | |
| INGSPISQKIIYKEN | 216 | P08603 | |
| FKEGTYKPIGFVNQL | 86 | Q9UI46 | |
| EKNLLYEFLGATKNP | 391 | Q6P1W5 | |
| LVYGAKLQPLDFKEN | 196 | P01008 | |
| LKDQITSGKYNFIPE | 436 | O96017 | |
| PSQLSIKQAFYGKLS | 1431 | Q8IXJ9 | |
| GTKLPKQTADFLQEY | 421 | Q9ULX6 | |
| LKQVVGGKLPVEFNY | 251 | Q9UPM8 | |
| EPPNNKLDKFSGTLY | 221 | P98198 | |
| SKAPIQQFADKLSGY | 926 | Q04656 | |
| PIDKKGNFNYIEFTR | 146 | P19105 | |
| PKDKFSYIGLSQNNL | 171 | Q96S59 | |
| YNPLLFTEKESGKLQ | 631 | Q9Y620 | |
| DELTSLLGYFPNKKQ | 561 | Q92878 | |
| PFSYKNVLSLTNKGE | 216 | P05556 | |
| IQGNLPFKLEKSYGN | 386 | O60330 | |
| QSGGKVADYIPQLAK | 241 | O94925 | |
| PLGKLTVAQIKAGYQ | 266 | Q9UGN5 | |
| NGKLKVESGQIYKNP | 1731 | Q8N7Z5 | |
| FTGFEPVQVQQYIKK | 871 | Q6ZW49 | |
| PGKAKFSLNYNTGLI | 406 | Q14517 | |
| TVRSPFLYNKDVNGK | 41 | Q9NXN4 | |
| SKGKTPALKYQQLFE | 811 | P33991 | |
| KSGENVAKFIINSYP | 111 | Q96EY7 | |
| PGQSEYNTIKDKFTR | 501 | Q460N3 | |
| DPQKYKGIFNGFSVT | 96 | Q00325 | |
| TDKKQISVGFIGYPN | 306 | Q13823 | |
| FINSEKPSGKIVYNI | 1491 | Q86XX4 | |
| RLEGFPQENSKYNKT | 366 | P41594 | |
| VSQFYLLPKGKQSIS | 611 | Q9Y5Z7 | |
| NKQLTGPTKGVIYLE | 726 | Q6DN14 | |
| KQQPLALGYFVSTAK | 2091 | Q71F56 | |
| NDVKNRSVYIKGFPT | 106 | P05455 | |
| TDASGKIEKYNVPLN | 181 | Q9UHB6 | |
| NKTGFVPSNYVERKN | 46 | P16333 | |
| NFIGSLNDQGYLLKK | 816 | Q9UJA3 | |
| NAAPLVKYFQEKGLI | 281 | Q9Y6K8 | |
| GNSKQYEIFKGTLKP | 381 | P16233 | |
| SIFTKYQTKPQLFGG | 81 | Q8IYA8 | |
| DNATLPQKLKEVGYS | 156 | Q5FYB0 | |
| NTPKLLTIYKENGQS | 191 | Q7Z3E5 | |
| KNQKYNVFTFIPGVL | 136 | O43861 | |
| GQLYDVLIKKNPFGI | 1976 | O43451 | |
| GLNLFNKKPEKGVQY | 531 | Q6DN90 | |
| YGFEKPSAIQQRAIK | 56 | P38919 | |
| LKKAGTNSPIFIQIY | 436 | Q8IVV2 | |
| LLDNVINYSFPAKGK | 406 | Q8TDD1 | |
| GRQAGFPKDYLQVKQ | 956 | Q8IY21 | |
| NVFVNDGSKLPQKFY | 1166 | Q9NRD8 | |
| LPDQGFFLYPKKISQ | 86 | Q9NR23 | |
| GKATFYKQLPQDLGT | 251 | Q96DC8 | |
| VSENVLGKPKKYQGF | 456 | O43424 | |
| YTKGAGKAPLNVQFN | 871 | O75369 | |
| LPTIFVYKNGQIEAK | 161 | Q8N4E4 | |
| GLEDPFNQKTLKYLL | 86 | Q99542 | |
| NPFIYSIKTKQIQSG | 286 | Q9H340 | |
| QYFGKKLSPENVAAA | 21 | P35913 | |
| LPGNLVEKVTNKNYV | 246 | Q9Y2G8 | |
| KDKNNYVGLVNIPTA | 241 | Q9UJF2 | |
| KNVPYVFVRSKQALG | 76 | P55769 | |
| KYSNKLQILNSIFPG | 171 | Q9NX47 | |
| KLVQKFPLGSYTIQN | 951 | Q9UIQ6 | |
| NYPQGLDDKTNIKTV | 51 | Q9NPD7 | |
| SKPGGYCLFIQKLQD | 426 | Q9H0R5 | |
| GNQDKFSYLPIQKGV | 686 | P23229 | |
| SENGPTVYNTLKKIF | 721 | A2A3K4 | |
| AKYTFGQPVQGKTQI | 231 | Q6IE36 | |
| ISENKFLKYLSQFGP | 86 | Q9NVV4 | |
| GLTQNKALPENVKYG | 36 | P49961 | |
| LLQPYGQEGLKSKSV | 526 | Q8WWQ2 | |
| QKRKYVLADPFNGIS | 16 | Q6ZSS7 | |
| YTPKEIFVANGTQGK | 41 | O95297 | |
| LGEIKTGNSPVKQYF | 176 | P20783 | |
| STFKNAKLYGPDVGQ | 256 | Q9Y251 | |
| STFKEGLEVKPILNY | 611 | P53708 | |
| DQPQLIKTLQKGEYF | 341 | Q13237 | |
| EFQKTLGGKQPVYDT | 6596 | Q9UPN3 | |
| FIKVPQNQNGKSKGY | 511 | P19338 | |
| SIQDKGSIQKFVPYL | 446 | P20839 | |
| NYAIIKPIGFNETAK | 446 | P26012 | |
| GKLKNYISEIQDSPQ | 401 | Q8NCM8 | |
| LKPENIVLYQKGQAS | 231 | Q9NR20 | |
| QCTLKEVYGFNPEGK | 96 | P04114 | |
| QKINYTVPQSGTFKI | 416 | Q6YHK3 | |
| PEVLNGQVSKYAKFV | 916 | Q9C0G6 | |
| QNKYPILFLTQGKSE | 516 | Q9NPB8 | |
| NGGFPIQSFRVEYKK | 631 | Q9BWV1 | |
| LGKKNESSYFPGNVL | 511 | P54132 | |
| YSFVKIINPQFKEEG | 101 | Q96PB1 | |
| VTLGDKKNYNQPSEV | 6 | Q8NCB2 | |
| YEGPTQKLFLKRNNV | 21 | Q9Y232 | |
| GIKPFLQYPSNEVNK | 1656 | Q9H799 | |
| QYGFVTPKKVLEALQ | 106 | Q4L180 | |
| IQNAPDKKITLNGIY | 91 | Q12948 | |
| TYKGRPFDFKQLITN | 171 | Q6VVX0 | |
| KQQPLFVSGGDDYKI | 61 | P53621 | |
| GSFKENSQYQPIKLQ | 1116 | P01031 | |
| QELYQFKKPGTNLTE | 276 | Q49AR2 | |
| QLKPGLQYKLVSQTG | 411 | Q12906 | |
| TEYVDKVNSQKPGFI | 206 | Q6P9A2 | |
| TLQKVYFKSNGSEPL | 71 | Q9Y5Q5 | |
| NKILPGLYIGNFKDA | 6 | Q9NRW4 | |
| YIPSFLKKEVQSAGQ | 546 | P20794 | |
| NPLEAGLEYFVKLNK | 736 | Q9UI17 | |
| SQVRKEPKTYFNGDL | 796 | Q8IWC1 | |
| IFYIKNENKLPTGGC | 151 | P13612 | |
| LPQFKEEPKNYVGTN | 196 | Q92538 | |
| PLIKGVFKGYNATVL | 71 | O95239 | |
| PLIKGIFKGYNATVL | 71 | Q2VIQ3 | |
| APAKFLGKQVLSYGQ | 561 | P11047 | |
| YKLKQEQGVESEPLF | 466 | Q8WUQ7 | |
| QKGTPNENKTILFYF | 81 | Q8NCS7 | |
| IQQEDSYPKGSKNIK | 406 | Q8IYX8 | |
| VALKTFELNGYQIPK | 376 | O43174 | |
| NPQNTIYDAKRFIGK | 91 | P48723 | |
| GVTQFGNKYIQQTKP | 16 | O43809 | |
| KYGIQADAKLQFTPQ | 81 | Q96AC1 | |
| KPEFLKRIGYGENNT | 51 | Q9NVP4 | |
| KYNFPQKITGGNLNV | 121 | A0A1B0GVD1 | |
| AQIKFLNTYQNPGEK | 246 | Q8ND90 | |
| TDKEKTLFQPQTGAY | 666 | P53992 | |
| SLQLFYGKKQPGKER | 71 | Q9BWG6 | |
| NLKGGKQLNKYDPFS | 686 | Q03701 | |
| DPGFVKQKVYNSKTG | 856 | Q14562 | |
| SKNPPAGYFQQKILE | 441 | Q9H6A0 | |
| FEPGTQRFELYKKAQ | 21 | Q70IA8 | |
| KYTTFKAGPILELEQ | 141 | Q96EY8 | |
| DTPYKQKQSGFFLEN | 1016 | Q3ZCN5 | |
| NYISKQLNPVFGKSF | 1531 | Q9HC10 | |
| NYTQEPPVQKGFLLK | 46 | Q9H4L5 | |
| KIDYGVFAKLPNLLQ | 131 | Q99983 | |
| FNKVLGKGPYQLSSL | 1246 | Q6ZRI0 | |
| KISLPIEDYFNKGKN | 21 | Q9UBD5 | |
| LEQKPKDFYAPQSQA | 826 | P56715 | |
| DVYLINPQGKAFRSK | 121 | P51608 | |
| NPELNQKGYSVKSDI | 226 | P52564 | |
| GPLKDNEQTIGFYTK | 771 | Q99683 | |
| KSQLLKDPQVLFAGY | 46 | Q9H1A7 | |
| DIYPENLNSKKKFGA | 61 | Q9H2B2 | |
| QLVAIYKTLGGEKFP | 231 | Q92777 | |
| YKTLGGEKFPLIEQT | 236 | Q92777 | |
| KYGFEPTQEGKLFQL | 116 | Q8IXM3 | |
| FGKNFSIAYNIVKIP | 196 | Q16518 | |
| FAKPGTEQYLLAKQL | 211 | Q9Y5X1 | |
| FGKTNIYTQKQEPPK | 126 | Q9H5V9 | |
| IQNSPQKKDSGGKVY | 11 | Q96MN5 | |
| SVYLENLQKPGFKSL | 66 | Q8N3R3 | |
| EQAKYLGLNKNGPFK | 591 | Q96HN2 | |
| QGFSYDLLKKIDSPQ | 156 | Q8IWB6 | |
| PNYKNFKGTIQELGQ | 911 | Q02880 | |
| PDTYGKLFLLNSVGQ | 541 | Q17RD7 | |
| YSKPIQGQQKKPFEE | 606 | P31040 | |
| KVKGYVSNISNPANF | 1296 | B5MCY1 | |
| KIQTLFLQYPEGEGQ | 736 | A0AVI2 | |
| AEQLKQYEINATPKG | 586 | Q8N3X1 | |
| GQKLLPNTLTDKFYV | 461 | Q9H3W5 | |
| QLTQPGKLTEAFKYF | 296 | Q9UN36 | |
| YLTKNKEGPQVSENL | 526 | Q8NI08 | |
| EGFSYVKIPNKPTQQ | 961 | P21675 | |
| TSSENQKPGGYLVFK | 1156 | Q587J7 | |
| KYPSGVAFKDLSQAQ | 211 | A0PJY2 | |
| DLQSPKKGNAIPYFQ | 181 | Q9NYQ3 | |
| TEYEQIPKKKANGIF | 911 | Q15678 | |
| KPFQDYQKLSSNLGG | 2056 | P48634 | |
| GNFSYQKNPLKLGEL | 326 | Q96PZ0 | |
| TIPGKQQLLIGAYAK | 426 | Q99832 | |
| QPGKLTEAFKYFLQG | 271 | Q9ULP0 | |
| SNKIETIPNGYFKSF | 251 | P51888 | |
| DQFLNGKPIRIGYKI | 556 | Q96JS3 | |
| YQIGTFKLAFVKEPQ | 216 | Q96P15 | |
| NELEGLKQKQISYSP | 661 | Q5VT25 | |
| GGNQPVKKSFLVYRN | 976 | P55201 | |
| YITKFKGFDPNQLSV | 451 | O00116 | |
| LTGNYVPSFLKKEIG | 551 | Q9UPZ9 | |
| YGESNLVAEPQKVNK | 616 | Q15003 | |
| NGVQIESKFPKGDYT | 501 | Q96M02 | |
| NKPADYFILILQGKV | 606 | Q6P4Q7 | |
| QGLAVYASPENKKLF | 126 | Q9BYD2 | |
| KSQLLKDPQVLFAGY | 46 | Q9GZM3 | |
| LGYAAIPIKFSEKQQ | 21 | Q9Y3A4 | |
| NYKSFLGINKERVPF | 971 | P48736 | |
| YDNKLQTISKGLFAP | 411 | O75094 | |
| VYNGKTFNQVEIKPE | 96 | P62841 | |
| AQYITDAEGLPKKFV | 3726 | Q63HN8 | |
| QLKVSNDGYKFSNPK | 1016 | Q8N2E2 | |
| YRKLVGNNPSKFVGQ | 151 | Q96PE6 | |
| FSDGTVNPQYKKAIL | 636 | Q9P2K2 | |
| PQLSAEFKNAVSKYG | 161 | Q70EL4 | |
| SPKYNETFQFILGKE | 2111 | Q8NB66 | |
| QQFSPTGKYKADGVL | 521 | Q4G0A6 | |
| FKLPNDDLQGIQKIY | 276 | P51512 | |
| EIGAKQVQKYVPLNS | 326 | Q5JS37 | |
| KGLRQGYFVEAQPKI | 136 | P02743 | |
| SQYKKVELFPNGQSV | 246 | P35247 | |
| QDVYKPKAVGNSGQL | 226 | Q8TDD2 | |
| KEIQSRPGNALYFKS | 91 | Q92629 | |
| KPQFDVSNATLKYKG | 126 | Q8N412 | |
| IEPFYKGGKAQLDQT | 21 | Q12788 | |
| GSKDLNNFIKVYPGT | 406 | O95171 | |
| NNFIKVYPGTEKSTE | 411 | O95171 | |
| TGPIDLAQKFGYKLV | 231 | Q9NS62 | |
| NLKFNKKNEEVPGYT | 956 | Q8IZH2 | |
| ILGSYDPQQIFKCKG | 376 | Q6Q0C0 | |
| TTENLGKKYVFLDPL | 176 | C4AMC7 | |
| NFKSYKGRQIIGPFQ | 11 | Q14683 | |
| VGALKSKYFPGQESQ | 196 | Q71RG4 | |
| DAIKNNSFYGPELKI | 701 | P47989 | |
| PGEYVLTFNFQGKAK | 451 | O14492 | |
| TNKFYEGQDNPGLIL | 421 | Q8TC07 | |
| PELYKQKSVDSEGNQ | 211 | Q6XYQ8 | |
| NTGDIQKYLTPKSQF | 221 | Q8IYW5 | |
| INGKLFLPKYALSQD | 56 | P01222 | |
| SYKNFKGTIEELAPN | 891 | P11388 | |
| DYIDFFNTKGLKNLP | 421 | Q96MP5 | |
| INYDFALPPNKSKGI | 671 | Q86YA3 | |
| FGLKEAPVQDQGYKT | 161 | P17098 | |
| YGKIISDGSNQKLPL | 231 | Q86WZ6 | |
| YGQEKSKEQTIPNFT | 61 | Q68EA5 | |
| YNKVFLAKGNIPAES | 241 | P48556 | |
| PLEQGVVAAFKQLYK | 416 | Q53EQ6 | |
| VENLKPNTVYEFGVK | 181 | Q7Z7G0 | |
| KLNGLFDSPVKEYQQ | 716 | Q8NFY4 | |
| NYKDKFEPGILQLSQ | 291 | Q8N8N7 | |
| KVEYQENGPLFSELK | 61 | Q86Y07 | |
| NTLFKAYPNKGVGQA | 1356 | Q14966 | |
| YENVAKVGFQLFKPS | 46 | Q96MR9 | |
| FYASVQKLFGPDVKN | 56 | B1ANS9 | |
| RPLGKIFQIYKGNFT | 211 | Q6UXF1 | |
| DNGQGPKYVKIFINL | 186 | O43396 | |
| EIKQPVFGANYIKGT | 81 | Q969T9 | |
| KNLATVGYQLFKPSL | 6 | Q14584 | |
| GKTQTIFLKYPQEKN | 811 | Q9NZM1 | |
| KNGQEIKPSSKYVFE | 291 | Q14324 | |
| AYKKGLAEQQAQFTP | 241 | P20929 |